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Abstract

ACCELERATING WHOLE-CELL BIOCATALYSIS
BY ENHANCING OUTER MEMBRANE PERMEABILITY

By Ye Ni, Ph.D.
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2006
Major Director: Rachel R. Chen, Ph.D., Gary S. Huvard, Ph.D.

Whole-cell biocatalysts are preferred in many biocatalysis applications. However,
cell envelope often represents a formidable permeability barrier. As a result, reactions
catalyzed by whole-cells are reportedly orders of magnitude slower than those of by their
free enzyme counterparts. The present research addresses this critical issue by using
membrane engineering approaches. Two E. coli strains with genetically altered outer
membrane structures were used in the study, a lipopolysaccarides (LPS) mutant SM101
and a Braun’s lipoprotein mutant E609L. The effects of outer membrane mutation on the
permeability of substrates differing substantially in size and hydrophobicity were
investigated by combining the mutant cells with model enzymes. The reduction of the
outer membrane permeability barrier by these mutations led to significant accelerations
x

xi
(2– to 14–fold) in reaction rates of all whole-cell catalyzed reactions investigated. In the
case of tetrapeptide, LPS mutation of the outer membrane can render the outer membrane
completely permeable to substrate, a barrier-less condition that maximizes the reaction
rate. For reaction rates of toluene dioxygenase (TDO)-catalyzed reactions, a dramatic
increase of up to six fold was observed with the lipoprotein mutant for each of the three
small, hydrophobic substrates tested. Mutations in either the LPS or in the Braun’s
lipoprotein are effective for accelerating reactions with UDP-glucose, resulting in a
striking acceleration (up to 14–fold) of reaction rate. The magnitude of reaction rate
acceleration was found to be dependent upon the substrate concentrations, the enzyme
expression level, and on the nature of the mutations and substrates. In addition, the
mutations have been demonstrated to be far more superior to common permeabilization
procedures like freeze-thaw (FT) or treatment with the chelating agent EDTA (ethylene
diamine tetraacetic acid). Importantly, lipoprotein mutant E609L exhibited a normal
growth rate and expressed the recombinant multi-component enzyme as well as the
isogenic parent. The exact nature of lpp lipoprotein mutation in E609L was further
studied and deletion of lpp was successfully introduced into E. coli strain with different
genetic background for whole-cell biocatalysis applications. An example was provided by
introducing an lpp deletion into an E. coli O44K74 strain to achieve a higher yield for Lcarnitine production. This research and the results outlined in this dissertation
demonstrate a valid strategy for addressing permeability issues in whole-cell biocatalysis.
The work also highlights a need for accessing substrate permeabilities in biocatalysis
research and development.

CHAPTER 1 Introduction

1.1 Background
Over the last two decades, the rising economic and medical importance of natural
products and an ever-increasing pressure to mitigate the adverse impact of synthetic
production practices have stimulated interest in the use of biocatalysis as a production
tool. According to estimatesT 1 , by 2010, the share of biocatalysis processes in the
production of various chemical products will increase from 5% to about 20%, about $280
billion increase in the market value of products produced using biocatalysis. Another
estimation2 showed that 30–60% of all fine chemicals production is anticipated to involve
a biocatalytic process step in 5 years.
Compared to isolated enzymes, whole-cell biocatalysis has a number of attributes
that are particularly attractive for large-scale applications. First, the use of whole cells
instead of free enzymes is more economical as the use of whole cell eliminates the need
for tedious, expensive protein isolation and purification. Also, whole cell biocatalysis
allows cascades of enzymatic reactions that involve multiple enzymes, cofactors, and
substrates while the same reaction might be too complicated to perform in vitro.
Moreover enzymes are generally more stable when protected by cell envelopes3, 4.
In general, the reactions catalyzed by whole cells are 10– to 100–fold slower than
rates observed for free enzyme reactions. The difference is usually attributed to the mass
transport barrier imposed by cellular envelopes. For example, isonovalal synthesis from
α-pinene oxide catalyzed by Pseudomonas rhodesiae whole cells was increased by 60–
1

2
fold after permeabilizing the cells . In another recent study, mass transfer across a
5

recombinant E. coli cell membrane caused a reduction in the Baeyer-Villiger oxidations
of biocyclo[3.2.0] by almost ten fold6. In a more dramatic case, intact Pseudomonas
pseudoalcaligenes cells showed no activity to maleate (substrate) in the process of Dmalate production; the cell membrane completely blocked the entry of the substrate7.
Other studies documenting the mass transfer limitations imposed by cell membranes
during whole-cell biocatalysis have also been reported8, 9, 10, 11, 12.
This often-encountered mass transport problem has thus far limited the
commercial application of whole-cell biocatalysis. Current permeabilizing methods
involve chemical treatments with detergents, solvents, chelators, or physical treatments
such as extreme temperature fluctuations. All these methods are highly empirical, and are
generally undesirable for large scale applications. Permeabilization treatments inevitably
create additional steps in manufacturing processes, complicate downstream processing,
and incur unintended damage to cells. Cell damage is particularly problematic as it
disrupts the normal membrane functions and intracellular metabolism needed for efficient
cofactor regeneration.
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1.2 Objectives
The goal of this research is to accelerate the whole-cell biocatalysis reactions via
genetic alteration of a cell membrane to mitigate or eliminate mass transport resistance to
substrates. Eventually, we hope to be able to rationally engineer the cell membrane to
enhance the permeability of a chosen substrate. The specific objectives of the study are:
1) To illustrate the use of two specific E. coli outer mutations (Lipid A and Braun’s
lipoprotein) to increase the permeability of substrates with different size and
hydrophobicity.
2) To establish the correlations between the effects of the mutations on mass transport
rates to the molecular properties of the substrates, and a generally applicable
membrane modification method to accelerate the whole-cell biocatalysis reaction rate.
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1.3 Rationale and Approaches
The outer membrane of Gram-negative bacteria cell envelope is a distinct
bilayered structure. It is chemically different from usual biological membranes and has
the ability to resist damaging chemicals. The outer leaflet of the outer membrane,
lipopolysaccharide (LPS), is a highly ordered quasi-crystalline structure with very low
fluidity and very low permeability to especially hydrophobic molecules. The LPS
consists of lipophilic Lipid A, an oligosaccharide core, and a long polysaccharide chain
comprising up to 40 sugars (called an O-specific chain). The hydrophilic polysaccharide
component is responsible for the exclusion of hydrophobic molecules and the
hydrophobic Lipid A of LPS limits the entry of hydrophilic compounds. The outer
membrane of Gram-negative bacteria excludes even small hydrophobic compounds, and
requires dedicated protein-based mechanisms for the entry of some larger hydrophilic
molecules smaller than 600–700 Daltons. Passive diffusion through porin channels of the
outer membrane is the mass transport mechanism for small hydrophilic compounds. Even
with porins, diffusion may be slower than desired10.
The rate of entry of molecules is often the rate-limiting step of a biocatalysis
reaction. Since many biocatalysis substrates are synthetic hydrophobic and/or relatively
big molecules and lack a natural uptake system, obtaining rapid substrate permeation
through outer membranes is a common and formidable obstacle in whole-cell
biocatalysis. In this study, we accelerate whole-cell biocatalysis by genetic modification
of the outer membrane of a host cell to increase the permeability of the cell membrane to
specific substrates. Two outer membrane mutants with genetic modifications at different
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sites of the outer membrane were studied. The first mutant has a mutation inactivated the
first enzyme in the LPS synthesis pathway, UDP-N-acetylglucosamine acyltransferase,
resulting in an approximately 30% reduction in LPS synthesis. Another modification
targeted a Braun’s lipoprotein, a structural protein that connects the peptidoglycan with
the inner leaflet of the outer membrane. This protein is the most abundant protein in a
numerical sense in E. coli. About one-third of the lipoprotein molecules are covalently
linked to murein and help hold the two structures together. Mutants defective in the
structural gene for this protein are fully viable, indicating the gene is nonessential.
However, the disruption of the lipoprotein likely affects the global membrane integrity
and thus may cause some changes in substrate permeability. Our approach is first to
interrogate the existing outer membrane mutants with different substrates and then
rationally engineer the cell membrane for the whole-cell biocatalysis application. The
approach is illustrated in Figure 1–1.

Figure 1–1.

Illustration of the mechanism and permeability assay of E. coli whole-cell

catalysis investigated in this study.
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1.4 Organization of the Dissertation
This dissertation comprises 6 chapters as follows.
Chapter 1. Introduction
Chapter 2. Markedly Enhanced Whole-Cell Catalyzed Reaction Rates by Genetic
Modification of Outer Membranes
Chapter 3. Acceleration of a Permeability Limited Toluene Dioxygenase–Catalyzed
Reaction via Lipoprotein Mutation
Chapter 4. The Effect of Outer Membrane Mutations on UDP–Glucose Permeability and
Whole-Cell Catalysis Rates
Chapter 5. The Significance and Application of lpp Lipoprotein Mutation in Whole-Cell
Biocatalysis
Chapter 6. Summary
The experimental chapters contain the data and analyses used to prepare the three
publications from these studies. Thus, the dissertation is organized according to the
chronology of the work carried out. Chapter 2–4 therefore cover different aspects of
genetic modification of cell membrane to enable improved permeability of interrogating
substrates. In all, we studied the effect of two membrane mutations on the permeability of
six substrates differing substantially in hydrophobicity and size.
In chapter 2, the effects of two outer membrane mutations on permeability of two
substrates with different hydrophobicity are reported. By combining these two mutants
with two model enzymes (β-lactamase and subtilisin) expressed in periplasmic space, we
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were able to quantify the effects of the mutations on reaction rates with their respective
substrates, nitrocefin (hydrophilic) and a tetrapeptide (hydrophobic).
In the work described in Chapter 3, the effect of lipoprotein mutation on the
permeability of three small, hydrophobic substrates was evaluated with another model
enzyme, toluene dioxygenase.
Chapter 4 reports the results of a study on Lipid A and lipoprotein mutations that
were interrogated using a relatively large and hydrophilic molecule, UDP-glucose. This
study considered two UDP-glucose utilizing reactions catalyzed by UDP-glucose
dehydrogenase and UDP-galactose 4’-epimerase/β-1,4-galactosyltransferase fusion
protein. The application of these mutants for whole-cell biocatalysis was illustrated by
synthesizing a disaccharide, N-acetyllactosamine.
Mutation of lpp lipoprotein had a significant effect on the permeability of all six
substrates tested. We therefore studied the genetic sequence of lpp lipoprotein mutation
and introduced this mutation into E. coli strains with different genetic backgrounds.
Chapter 5 discusses the effectiveness of this mutation on the production of L-carnitine by
E. coli O44K74 strain with lpp lipoprotein to achieve a higher yield of production.
The significance and the potential impact of this research are summarized in
Chapter 6. This final chapter also reiterates the major finding of these studies and offers
recommendations for the future work.

CHAPTER 2
Markedly Enhanced Whole-Cell Catalyzed Reaction Rates by Genetic Modification
of Outer Membranes
Whole-cell biocatalysts are preferred in many biocatalysis applications3,4.
However, due to the permeability barriers imposed by cell envelopes, whole-cell
catalyzed reactions are often 10–to–100 times slower than reactions catalyzed by free
enzymes. In this study, we reduced the membrane permeability barrier of E. coli strains
by genetically altering the membrane structure. A lipopolysaccarides E. coli mutant
(SM101) and a Braun’s lipoprotein mutant (E609L) were used in this study. Two model
substrates that differ substantially in size and hydrophobicity, nitrocefin and the
tetrapeptide N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, were employed to interrogate the
outer membrane of the cells. The reduction of the outer membrane permeability by
genetic methods led to significant increases (up to 380%) in reaction rates of whole-cell
catalyzed reactions. The magnitude of the increase in biocatalysis rates was dependent on
the substrates and on the nature of the mutations introduced in the outer membrane
structure. Notably, some outer membrane mutations can render the outer membrane
completely permeable to one substrate, a barrier-less condition that maximizes the
reaction rate. The impact of the mutations introduced on the permeability barrier of the
membranes was compared to the impact of polymixin B nonapeptide, a known potent
permeabilizer acting on lipopolysaccharides. Based on our findings, genetic
modifications to enhance the permeability of hydrophilic molecules should target the
Lipid A region. However, molecular engineering strategies other than reduction of Lipid
8

9
A synthesis should be considered. As we have demonstrated with tetrapeptide, membrane
engineering can be much more effective than exogenous permeabilizers in reducing the
permeability barrier imposed by cell walls. To our knowledge, this study is the first use of
molecular membrane engineering techniques to address the substrate permeability
limitations encountered in biocatalysis applications.
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2.1 Introduction
Whole cell biocatalysis are preferred to purified enzymes especially for largescale applications because it is usually more economical, easier and stable to use,
particularly for reactions involving multiple enzymes or cofactor regenerations, . However,
whole cell biocatalysis generally exhibits much slower reaction rates than does the use of
free enzymes due to the mass transfer limitations imposed by low permeability cellular
membranes. This often-encountered difficulty limits the application of whole-cell
biocatalysis. It’s been recently reported that the membrane permeability barrier cause a
reduction in the reaction rate for about 60–fold in a study of whole-cell catalyzed
isonovalal synthesis from α-pinene oxide, almost ten fold for a Baeyer-Villiger
oxidations with recombinant E. coli

cells. And more dramatically, the intact

Pseudomonas pseudoalcaligenes cells showed no activity to maleate (substrate) in Dmalate production.
Current permeabilizing methods involve physical and/or chemical treatment of
host cells. These methods are generally developed by trial-and-error and inevitably add
several steps to a bioprocess synthesis. For example, permeabilizing cells with 1 %
toluene, a commonly used procedure, requires five steps 11 . In addition, permeabilizer
residues complicate downstream purification processing, especially when a surfactant is
used to permeabilize the cell. Furthermore, excessive membrane damage and cell lysis
are often observed when chemical permeabilizing agents are employed. Such damage
precludes efficient cofactor regeneration since the regeneration process requires normal
membrane function and intracellular metabolism.

11
The molecular basis of permeability limitations is well-known. The outer
membrane of Gram-negative bacteria12 (Figure 2–1A) excludes even small hydrophobic
compounds, and allows the entry of some larger hydrophilic molecules (<700 Daltons)
through dedicated protein-based structures, aptly called porins. Passive diffusion through
porin channels (Figure 2–1A) of the outer membrane is the mass transport mechanism for
small hydrophilic compounds. Even with porins, diffusion may be slower than desired.
The lipopolysaccharide (LPS) (Figure 2–1A and Figure 2–1B) monolayer is a highly
ordered, quasi-crystalline structure with very low fluidity, and the layer does not allow
rapid diffusion of molecules. The LPS (Figure 2–1B) comprises lipophilic Lipid A, an
oligosaccharide core, and a long polysaccharide chain containing up to 40 sugars
(indicated in Figure 2-1B as the O-specific side chain). The hydrophilic polysaccharide
component is responsible for the exclusion of hydrophobic molecules and the
hydrophobic Lipid A of LPS limits the entry of hydrophilic compounds.
The molecular size and/or hydrophobicity of most biocatalysis substrates of
commercial interest limit or preclude their entry into host cells by naturally established
transport mechanisms. The concomitant limitation of biocatalysis reaction rates is
therefore a commonly encountered and formidable obstacle to the commercialization of
whole-cell biocatalysis synthesis.

12

(A)

(B)
Figure 2–1. A: Gram-negative envelope. B: Lipopolysaccharide structure. (adopted
from Prescott et al., 2002)
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In order to mitigate the mass transport limitations in whole-cell biocatalysis
systems, we are genetically altering the barrier membrane to increase the transport rates
of chosen substrates through the membrane. In this study, the effects of genetic
modifications at two sites of the outer membrane were investigated. One modification
affects the LPS synthesis pathway. An LPS mutant with approximately 30% reduction in
LPS synthesis was used to probe the changes in biocatalysis reaction rates caused by the
mutation. Another membrane modification targeted a Braun’s lipoprotein (Figure 2–1A),
a structural protein that connects the peptidoglycan with the inner leaflet of the outer
membrane. In order to isolate the outer membrane for permeation studies, the model
enzymes we used (β-lactamase and subtilisin) were expressed in periplasmic space. Their
respective substrates, nitrocefin and a tetrapeptide, differ substantially in size and
hydrophobicity, and were used as model substrates to probe the mutation effect on
reaction rates.

14
2.2 Experimental
2.2.1 Chemicals
All chemicals were reagent grade and used as received. Nitrocefin was obtained
from Oxoid Ltd. (Basingstoke, Hampshire, United Kingdom). Tetrapeptide, N-succinylAla-Ala-Pro-Phe-p-nitroanilide (AAPF-pNA) and polymyxin B nonapeptide (PMBN)
were obtained from Sigma (St. Louis, Mo).
2.2.2 Sterile control
All vessels and media used for cell cultures were autoclaved at 121oC for 15
minutes. All tips, pipettes and tubes were purchased in disposable, sterile form. All cell
culture operations were performed in a class II biological safety cabinet to avoid airborne contamination.
2.2.3 Escherichia coli strains and plasmids
E. coli strains and plasmids used in this study are shown in Table 2–1. pBR322 is
a commonly used cloning vector in E. coli with a low copy number of about 20 per cell.
pBR322 contains bla gene, coding for β-lactamase that confers resistance to ampicillin.
The expression of β-lactamase is constitutively driven by P1 and P3 promoters (no
inducer required), and the expression level is comparable between strains13, 14. The signal
sequence in bla gene allows translocation of β-lactamase to periplasmic space15.
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Plasmid pGES201 was graciously supplied by Dr. Dordick (RPI). This plasmid
was constructed by inserting WT-sprE (a wild-type gene for subtilisin E) into a
commercial pBAD/gIII plasmid (Invitrogen) for periplasmic expression of subtilisin E.
The signal peptide from the bacteriophage fd gene III (gIII) permits secretion of subtilisin
E into periplasmic space. araBAD promoter (pBAD) provides tight (low basal expression
level without inducer L-arabinose), dose-dependent regulation of WT-sprE gene
expression using arabinose as an inducer16.
Two types of E. coli host strains were used in this study. The lipid A mutant
SM101(lpxA2) is a thermo-sensitive, UDP-N-acetylglucosamine acyltransferase (lpxA)
defective strain17, . Its isogenic parent strain, SM105, was used as a control. E609L is a
periplasmic leaky E. coli host in which the gene encoding Braun’s lipoprotein was
disrupted by a Tn10 insertion into the lpp gene18. E609 was its isogenic parent and was
used as a control.
Strains SM101/pBR322, SM105/pBR322, E609L/pBR322 and E609/pBR322 for
study with nitrocefin were constructed by transforming the four host strains (Table 2–1)
with plasmid pBR322 using a Bio-Rad Micropulser following the standard procedures19.
Similarly,

strains

SM101/pGES201,

SM105/pGES201,

E609L/pGES201

and

E609/pGES201 were constructed by transformation of the host strains with plasmid
pGES201 for study with tetrapeptide.
Figure 2–2 is a block diagram illustrating the experimental protocol used in this
study. Detailed descriptions of the procedures referred to in the various blocks in Figure
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2–2 follow below. Additionally, the terms used for various preparations (i.e., supernatant,
cell pellet, etc.) are indicated in Figure 2–2 as a quick reference for the reader.

Table 2–1. E. coli strains and plasmids used in this study.
Description
Strains
SM101
SM105
E609L
E609
Plasmids
pBR322
pGES201

Source

HfrC pps, isogenic parent of E609L

M. Vaara
(Martti.Vaara@Helsinki.fi)
M. Vaara
K. W. Miller , 25
(labcin@uwyo.edu)
K. W. Miller , 25

periplasmic β-lactamase encoding
plasmid
subtilisin E ( serine protease) gene
WT-sprE in pBAD/gIII

R. I. Lehrer
(rlehrer@mednet.ucla.edu)
J. Dordick
(dordick@rpi.edu)

lpxA2 mutant, thermosensitive,
grows well at 28oC
lpx A2+, isogenic parent of SM101
lpp::Tn10; periplasmic leaky; Tcr
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1. Recombinant strain preparation: transformation of plasmid into the host strain
by electroporation (as described in 2.2.3).

2. Seed culture preparation: inoculate liquid culture stored at -80oC in 15 %
glycerol (v/v) into 5 ml of LB medium and incubate overnight as a seed culture (as
described in 2.2.4).

3. Cell preparation: inoculate an overnight seed culture into 10 ml of LB medium
for whole cell preparation. Cells were harvested by centrifugation and washed once.
Centrifuged cells are recovered as “pellet”. (as described in 2.2.4, 2.2.5).
cell pellet
4. Whole-cell activity:
cell pellets were resuspended in
buffer for whole-cell activity assay
(as described in 2.2.4, 2.2.5, 2.2.7).

cell pellet
5. Lysozyme/osmotic shock
treatment: periplasmic fraction
extraction (as described in 2.2.6).
pellet

supernatant
Sonication and centrifugation
6. Periplasmic fraction activity:
supernatant from lysozyme/osmotic
shock treatment was analyzed for
periplasmic fraction activity
(as described in 2.2.6).

supernatant
7. Activity in supernatant

8. Cell-free extract activity: combined activity from blocks 6 and 7
Figure 2–2. Block diagram illustrating the sequence of preparative steps and assays used
for the measurements reported in this study.
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2.2.4 Whole-cell β-lactamase activity assay with nitrocefin
All pBR322 transformants were grown in LB medium. The LB medium contained
10g/L tryptone, 5 g/L bacto-yeast extract, and 10g/L NaCl. SM101/pBR322,
SM105/pBR322, E609L/pBR322 and E609/pBR322 were grown in 10 ml of LB medium
containing 50 µg/ml ampicillin (to maintain selective pressure for ampicillin resistant
gene carrying plasmid pBR322 in these strains) in a 50 ml flask and each inoculated with
an overnight culture of (2% inocula). SM101/pBR322, which is thermo-sensitive, was
grown at 28 oC; the others were grown at 37oC. All cultures were continuously shaken at
250 rpm until OD600 (the optical density at 600 nm) reached around 0.5. Cells were
harvested by centrifugation at 4000 × g for 10 minutes at 4oC and washed once with 10
mM sodium phosphate buffer (pH 7.4) using a pipette. Cell pellets were then prepared by
centrifugation. The pellets were isolated and then resuspended in 5 ml of sodium
phosphate buffer (pH 7.4). Resuspension was accomplished by covering the cells with the
buffer and then drawing the mixture into a pipette.
The nitrocefin reaction rates were measured by the Angus method with some
modifications 20 . The reaction was carried out in a micro-cuvette. 100 µl of cell
suspension prepared as above was diluted with 860 µl of 10 mM sodium phosphate buffer
(pH7.4). The reaction was started by adding 40 µl of 0.5 mg/ml nitrocefin (20 µg/ml final
concentration). The total assay volume was 1 ml. Initial velocities of nitrocefin cleavage
(extinction coefficient ε500 = 15,000 M–1 cm–1) were monitored by measuring the
absorption at 500 nm at room temperature with a UV/VIS spectrophotometer (Lambda 40
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Spectrometer, Perkin Elmer). Similar preparations without cell suspension or without
nitrocefin addition were used as controls. One unit of β-lactamase activity was defined as
the amount of enzyme required to hydrolyze 1 µmol of nitrocefin per minute at room
temperature (typically 22°C ± 1°C). The typical range of cell density (absorption at 600
nm) for a reaction mixture was between 0.09 OD600 and 0.11 OD600 (corresponding to
about 0.2 g wet cell/liter). The activities were normalized by OD600 to correct for small
differences in cell density between the various preparations.
2.2.5 Whole-cell subtilisin activity assay with tetrapeptide
The expression of functional subtilisin E in E. coli strains was performed
according to methods described in the literature. 10 ml of LB medium with 100 µg/ml
ampicillin in a 50 ml flask was inoculated with an overnight culture of SM101/pGES201,
SM105/pGES201, E609L/pGES201 and E609/pGES201 (2% inocula). The thermosensitive SM101/pGES201, which is thermo-sensitive, was grown at 28 oC; all others
were grown at 37 oC. All cultures were continuously shaken at 250 rpm until OD600
reached around 0.5. Cells were harvested by centrifugation at 4000 × g for 10 minutes at
4oC and resuspended in a complete minimal (CM, an enriched medium containing all of
the growth requirements of a strain) of equal volume. CM Medium contained 10.50 g/L
K2HPO4, 11.25 g/L KH2PO4, 1.00 g/L (NH4)2SO4, 0.50 g/L sodium citrate·2H2O, 0.25
g/L MgSO4·7H2O, and 0.015 g/L CaCl2·2H2O. Other supplements included all 20 amino
acids at a final concentration of 40 µg/ml each, 5 mg/L vitamin B1, 0.20 % (v/v) glycerol,
and 100 µg/ml ampicillin. Inducer arabinose was added to a final concentration of 0.10 %
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(w/v). After induction, the incubation continued for 2–to–6 hours at 20 C with shaking to
o

achieve comparable expression levels. 100 µl cells were harvested by centrifugation at
4000 × g for 10 minutes at 4 oC. Cell pellets were resuspended in 200 µl of 10 mM
sodium phosphate buffer (pH 7.4) and AAPF-pNA was added to a final concentration of
300 µM. The reactions were carried out in 96-well microtiter plates for 120 minutes at 30
o

C. Initial velocities of p-NA release (extinction coefficient ε405 = 9.33 × 10-3 µM-1 cm-1)

from AAPF-NA were measured spectrophotometrically at 405 nm in a Wallac 1420
Victor3 Multi-label Counter (Perkin Elmer). One unit of subtilisin E activity was defined
as the amount of enzyme required to hydrolyze 1 µmol of AAPF-pNA per minute at 30
o

C. As with β-lactamase activities, subtilisin activities were normalized by absorption

measured at 600 nm to correct for small differences in cell density between samples.
2.2.6 Preparation of periplasmic fractions
A combined lysozyme and osmotic shock treatment 21 was used to extract the
periplasmic fraction. Cell pellets harvested from 4 ml of broth were resuspended in 2 ml
of OSI (osmotic shock buffer I) containing 100 µg/ml lysozyme. The OSI contained 200
mM Tris-HCl (pH 7.8), 2.5 mM EDTA, 2 mM CaCl2, and 20% sucrose. The suspension
was incubated quiescently at room temperature for 15 minutes before an equal volume of
ice-cold, deionized water was added. The suspension was incubated for another 15
minutes and then centrifuged at 13000 × g for 15 minutes at 4 oC. The supernatant was
analyzed for either β-lactamase or subtilisin activities using the same method as described
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in whole-cells (see Section 2.2.5). The activity measured was assigned as the periplasmic
activity (Block 6, Figure 2–2).
2.2.7 Preparation of cell–free extract
The pellets from the last step of periplasmic fraction preparation (Block 6, Figure
2–2) were resuspended in 2 ml of 10 mM sodium phosphate buffer (pH 7.4) containing 5
mM DTT (dithiothreitol). This was followed by ultrasonication (70 Watts output, 15 s × 4
bursts with 45 s intervals). The supernatant was collected after centrifugation at 13000 ×
g for 15 minutes at 4oC and was analyzed for either β-lactamase or protease activity as
described in 2.2.4 and 2.2.5. The activity was added to the periplasmic activity to obtain
the cell-free extract activity (Block 8, Figure 2–2).
2.2.8 Polymyxin B Nonapeptide Permeabilization
PMBN treatment was conducted by pre-incubating the cells with 50 µg/ml PMBN
for 5 minutes at room temperature before reaction.

22
2.3 Results
Two outer membrane mutants with their respective isogenic parents were used in
this study. One mutant, SM101, carries a mutation in the lipopolysaccharide (LPS)
synthesis pathway (Table 2–1). In particular, the thermo-sensitive mutation occurs at
lpxA, which encodes UDP-N-acetylglucosamine O-acyltransferase, the enzyme that
catalyzes the first step of lipid A biosynthesis22. As a result of this mutation, both lipid A
and lipopolysaccharide synthesis were significantly reduced.

At a permissive

temperature (below 37 oC), the mutant produces 30% less lipid A than the control strain , ,
23

. The reduced LPS synthesis is thought to be compensated by glycerophospholipid,

resulting in a hybrid outer leaflet of the outer membrane. Previously, the E. coli strain
carrying this mutation was found to be particularly susceptible to hydrophobic antibiotics.
The MICs (minimal inhibitory concentration) of a large number of antibiotics for the LPS
mutant are 30– to–1000–fold lower than for its parent24.
The other outer membrane mutant (E609L) used in this study carries a transposon
mutation in a structural protein called Braun’s lipoprotein. The function of this
lipoprotein is to maintain rigidness and integrity of the outer membrane by linking the
inner leaflet of the outer membrane with the peptidoglycan (Figure 2–1A). As a result of
the mutation, the cells were susceptible to chelating agents (such as ethylene diamine
tetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA)), as manifested by a
decrease in cell density OD600. Some leakage of proteins was also observed , 25.
Table 2–1 shows the four strains and two plasmids used in this study. In order to
focus our study on outer membrane permeability, we used two plasmids that directed the

23
expression of two enzymes of interest into the periplasmic space. Plasmid pBR322 carries
a gene coding for β-lactamase along with its signal sequence that allows secretion of the
expressed enzyme to the periplasmic space. Plasmid pGES201 allows periplasmic
expression of subtilisin, a serine protease.
Mutant strains SM101, E609L and their respective isogenic parents were
transformed with either pBR322 (β-lactamase) or pGES201 (subtilisin). No appreciable
differences in growth behavior were observed between E609L and E609. SM101 grew
slightly slower than SM105 (according cell density OD600 measurement), with a doubling
time about 20% longer than the wild type grown at 28oC in LB medium. Whole cells of
these transformants were prepared as described in the Experimental section. Enzyme
activities were measured and were compared to the activities of periplasmic and cell
extracts.
The permeabilizing effect of polymixin B nonapeptide (PMBN) on whole cell
reactions with nitrocefin and tetrapeptide was also studied. PMBN is a proteolytic
product from the natural antibacterial peptide Polymixin B (PMB). PMBN, an extremely
poor antimicrobial agent, is about 100–fold less toxic to E. coli cells than PMB, but is
structurally similar to its parental compound and is still capable of binding to Lipid A.
Consequently, PMBN is a good outer membrane permeabilizer for gram-negative
bacteria26, 27.
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2.3.1 Reaction with nitrocefin substrate
Nitrocefin (MW = 516.5, Figure 2–3A) is a substrate for β-lactamase. Nitrocefin
is a relatively hydrophilic molecule compared to the other substrate used in this study, the
tetrapeptide (MW = 624.6, Figure 2–3B). The penetration of nitrocefin into the host cells
is hindered by the presence of the outer membrane28. β-lactamase activities measured
with nitrocefin as the substrate are tabulated in Table 2–2A. The activities of cell-free
extract for all four constructs were similar, indicating a similar level of the β-lactamase
expressions by each strain. Therefore, neither mutation in the outer membrane structure
of the host cells significantly affects the ability of the cells to synthesize the recombinant
enzymes. As well, the mutant cells maintained the ability to recognize and cleave the
signal peptide sequence, and folded β-lactamase in the periplasm to its correct
conformation.

NH
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B. N-succinyl-Ala-la-ProPhe-p-nitroanilide
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Figure 2–3. A: Chemical structure of nitrocefin. B: Chemical structure of N-succinylAla-Ala-Pro-Phe-p-nitroanilide.
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Notably, whole-cell activities are significantly lower than the activities of either
the periplasmic fraction or the cell extract. The activities expressed as a percentage of the
respective cell-free extract activities are tabulated in Table 2–2B. Whole cells had only
5%–to–20% of the cell-free extract activity, indicating the rate-limiting effect of the cell
membranes. Since the enzyme is expressed in the periplasmic space, the main penetration
barrier is the outer membrane (Table 2–2A and 2–2B). LPS mutation increased the
activity of the whole cells from 0.088 to 0.13 Units/OD

600

Cell (Table 2–2A), or

percentage activity increase from 13%–to–20%, (50% increase, Table 2–2B). An increase
in the percentage activity from 5%–to–18% after lipoprotein mutation was also observed
(a 3.8–fold increase). Although a measurable increase in the reaction rate accompanied
each mutation, the permeability resistance of the outer membrane to nitrocefin still
existed.
Table 2–2A. β-lactamase activity.
Strains

Whole-cell

SM101/pBR322
SM105/pBR322
E609L/pBR322
E609/pBR322

0.13 ± 0.03
0.09 ± 0.02
0.12 ± 0.01
0.03 ± 0.01

a

Activity (Units/OD600 cell)a
Periplasmic
Cell-free
PMBN
fraction
extract
treated cells
0.61 ± 0.06 0.63 ± 0.09 0.25 ± 0.03
0.67 ± 0.12 0.68 ± 0.10 0.49 ± 0.06
0.63 ± 0.09 0.63 ± 0.07 0.33 ± 0.07
0.69 ± 0.11 0.71 ± 0.11 0.59 ± 0.13

All results are averages of at least three separate experiments and are represented as

means ± 1 standard deviation.
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Table 2–2B. Percentage β-lactamase activity.
Percentage Activity
(with respect to cell-free extract)
Whole-cell a
PMBN treated cellsb

Strains
SM101/pBR322
SM105/pBR322
E609L/pBR322
E609/pBR322
a

b

20
13
18
4.8

39
71
52
83

Activity of whole - cell (Table 2a)
× 100
Activity of cell - free extract (Table 2a)
Activity of PMBN - treated cells (Table 2a)
× 100
Activity of cell - free extract (Table 2a)

Higher rates were observed when a peptide permeabilizer, PMBN, was employed.
For PMBN-treated cells, percentage activities reached 40%–to–80% of the respective
cell-free extract levels (Table 2–2B), indicating the importance of the Lipid A region as a
permeability barrier. A comparison of whole cell activities with and without PMBN
treatment is shown in Figure 2–4, a plot of activity ratios for treated and untreated cells.
The effect of permeabilizing with PMBN is more pronounced for wild-type cells than for
mutant strains. This is not surprising for the LPS mutant, as less Lipid A was synthesized
in the mutant and, consequently fewer PMBN binding sites were available in the
membrane. The reason for a greater effect on permeation of PMBN toward E609
compared to E609L is not yet understood.
Interestingly, the two wild-type strains (SM105 and E609) exhibited significant
differences in whole-cell activities. E609 had an activity of 0.034 units, a result 2.6–fold
lower than the activity of 0.088 units measured for SM105. This difference is not due to
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the expression level of the enzymes, as both strains have a similar level of expression as
judged by the activities in the cell-free extract. Rather, the difference may be attributed to
the different outer membrane structures that result from their different genetic
background. Particularly, if the Lipid A concentration in the outer membrane outer leaflet
was significantly higher in E609 than SM105, one would expect to see lower whole-cell
activities but more pronounced PMBN effects on permeability in E609. The observed
activities are consistent with this hypothesis (Table 2–2 and Figure 2–4) but further
confirmation of this explanation is desirable and should be addressed in future studies.

SM101/pBR322
SM105/pBR322

Nitrocefin

E609L/pBR322
E609/pBR322
SM101/pGES201
SM105/pGES201

Tetrapeptide

E609L/pGES201
E609/pGES201
0 1 2

4

6

8

10

12

14

16

18

20

Activity Ratio of Treated/Untreated Cells

Figure 2–4. PMBN permeabilizing effect. Error bars represent standard deviations from
the mean. All activities are averages of the results from at least three
separate experiments.

The Lipid A region is very hydrophobic and therefore suspect as the barrier for
hydrophilic molecules such as nitrocefin. Accordingly, PMBN is highly effective in
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increasing the outer membrane permeability to this substrate. Yet, reduction of Lipid A
synthesis by LPS mutation is less effective for this purpose. This may be due to the
hybrid outer membrane structure that results from LPS mutation. The reduced Lipid A
may have been replaced with other hydrophobic lipid molecules by a compensatory
mechanism, effectively diminishing the effect of reduced Lipid A in increasing
permeability. Genetic modifications of the fatty-acid moiety of Lipid A may be more
effective in reducing the resistance of the outer cell membrane to hydrophilic molecules
(Figure 2–1B).
2.3.2 Reaction with a tetrapeptide substrate
We have also investigated the transport of the tetrapeptide N-succinyl-Ala-AlaPro-Phe-p-nitroanilide (AAPF-pNA, Figure 2–3B) across the cell walls of our E. coli
strains. To our knowledge, the outer membrane permeability to this substrate has not been
investigated. In a previous study, whole cells with periplasmically-expressed subtilisin
exhibited some activity, indicating some permeability through the outer membrane.
However, the authors did not identify low cell-wall permeability as the rate-limiting step
in the synthesis.
The effect of mutations on the reaction rate of the tetrapeptide was investigated in
the present study. Four strains (Table 2–1) were transformed with plasmid pGES 201,
which carries a gene coding for subtilisin E. The expression of the enzyme is driven by an
arabinose-inducible promoter. The majority of the enzyme activity was found in
periplasmic space (Table 2–3A). Judging by the activity levels in cell-free extract, both
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mutants had lower expression of the enzyme than the wild types. SM101 had an
expression level about 15% lower than the parental strain and the expression level in
E609L was about 25% lower than that in the wild type. Despite the lower expressions,
mutant whole-cells exhibited activities either similar to (E609 pair) or significantly higher
(SM pair) than the activities obtained by their respective parental stains (Table 2–3A,
column 1), indicating increased permeability by either mutation.
When whole-cell activities are compared with their respective cell-free extract
activities, wild-type cells SM105/pGES201 and E609/pGES201 have about 46% and
60%, respectively, of their associated cell-free extract activities. The existence of a
permeability barrier to AAPF-pNA in each cell type is indicated. Mutation of LPS
increased the whole-cell activity to 95% of the cell-free extract level, or 105% of the
periplasmic level. This result is particularly striking as it implies that the mutation
rendered the whole-cells completely permeable to the tetrapeptide and eliminated the
mass transport resistance. Whole-cell catalysts reach a membrane-less or barrier-less
condition that maximizes reaction rates. Lipoprotein mutation was also effective in
increasing the permeability of the substrate. The reaction rates for whole-cells reached
about 80% of their cell-free extract level or 94% of their periplasmic level. Thus, for this
mutant, the mass transport limitation imposed by the outer membrane was almost totally
eliminated.
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Table 2–3A. Subtilisin activity.
Strains

Whole-cell

SM101/pGES201
SM105/pGES201
E609L/pGES201
E609/pGES201
a

3.9
2.2
6.7
6.4

± 0.5
± 0.4
± 0.8
± 0.7

Activity (mUnits/OD600 cell)a
Periplasmic
Cell-free extract
fraction
3.7 ± 0.3
4.1 ± 0.2
4.6 ± 0.4
4.8 ± 0.4
7.1 ± 0.8
8.1 ± 0.9
10 ± 1.1
11 ± 1.2

PMBN treated
cells
4.1 ± 0.4
2.6 ± 0.3
6.7 ± 0.7
6.9 ± 0.7

All results are averages of at least three separate experiments and represented as means

± 1 standard deviation. Activities are in milli-units.
Table 2–3B. Percentage subtilisin activity.
Percentage Activity
(with respect to cell-free extract)
Whole-cella
PMBN treated
cellsb
SM101/pGES201
95
100
SM105/pGES201
46
54
E609L/pGES201
82
82
E609/pGES201
59
64
Activity of whole - cell (Table 3a)
a
× 100
Activity of cell - free extract (Table 3a)
Strains

b

c

Percentage Activity
(with respect to periplasmic fraction)
Whole-cellc
105
48
94
66

Activity of PMBN - treated cells (Table 3a)
× 100
Activity of cell - free extract (Table 3a)
Activity of whole - cell (Table 3a)
× 100
Activity of Periplsmic fraction (Table 3a)

The PMBN permeabilizing effect was also investigated with tetrapeptide. The
ratios of activities of treated cells to the activities of untreated cells are plotted in Figure
2–4. The activity ratios for PMBN-treated cells relative to untreated cells are in the range
of 1.0 to 1.2, indicating only a small reduction in the barrier to permeation for the
tetrapeptide. This is expected for mutant strains, as they no longer experience any
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hindrance to permeation through the outer membrane. However, the minimal effect of
PMBN on wild-type strains is in sharp contrast with the results from studies with
nitrocefin, for which the ratios fell in the range of 2–to–18 (Figure 2–4) and for which the
more pronounced effect was observed for the wild type strains. The difference in
hydrophobicity of the two substrates may be responsible for this observation. PMBN acts
by binding to Lipid A of the LPS, the highly hydrophobic region of the outer membrane.
Based on the solubility of nitrocefin in an aqueous solution that did not dissolve the
tetrapeptide, we consider the tetrapeptide to be more hydrophobic than nitrocefin.
Therefore, the tetrapeptide can be expected to permeate through the Lipid A region more
quickly than does the nitrocefin.
The LPS mutation and lipoprotein mutation do not cause detectable leakage of the
β-lactamase or subtilisin under the conditions used for whole-cell activity assay. This was
ascertained by measuring the respective activities of the supernatant samples taken during
whole-cell reactions under identical experimental conditions. The supernatant showed
negative β-lactamase or protease activity. Therefore, the increased whole-cell activity is
attributable to increased permeability via mutations rather than to leakage of the enzymes.
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2.4 Discussion
The substrate permeation barrier presented by cell envelopes is the underlying
cause of low whole-cell biocatalysis rates. In this study, significant acceleration of wholecell biocatalysis was achieved by reducing the barrier properties of the outer membrane
via genetic modifications of the outer membrane structure. In the case of the tetrapeptide,
mutation of the outer membrane accelerated the biocatalytic reaction to its maximum
since the cellular membrane no longer impeded mass transport of the enzyme reactants.
By using a single mutation, whole-cell biocatalysis exhibited the same rates as for free
enzymes, yet all the advantages of whole-cell catalysis were preserved.
For the nitrocefin reaction, however, the same mutations had less impact on
increasing the whole-cell reaction rates and only about 20% of the achievable cell-free
extract level was measured. The gains to be realized by mutating the outer membrane are
therefore dependent on the nature of the substrate. The results of experiments using
PMBN to increase substrate permeation rates indicate the importance of the relative
hydrophobicities of the substrates. This explanation is consistent with the earlier studies,
which showed that E. coli cells with an LPS mutation were particularly susceptible to
hydrophobic antibiotics due to increased permeability. Other differences, such as the
molecular size of substrates and their ability to carry an ionic charge, certainly contribute
to the differences in mass transport rates across the genetic altered cell walls.
To further probe the relationship of membrane permeability to the substrate
molecular structure, the E. coli mutants could be interrogated with substrates of
systematically varied sizes, hydrophobicities, and ionic charges. Other mutants,
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engineered to allow passage of particular molecular structures, could also be developed.
Understanding these relationships is important for predicting the effects of genetic
modifications on catalysis rates and can ultimately lead to other rational approaches for
modifying cellular membranes. This study was one step toward that goal.
In the case of tetrapeptide, mutations of the outer membrane structure resulted in a
significant increase in permeability, whereas treatment with PMBN had little effect.
Modifying the membrane structure genetically was more effective in increasing the
permeation rate of tetrapeptide, than was treatment with the permeabilizer, strongly
supporting our rationale for pursuing genetic alterations as a means of improving wholecell biocatalysis rates. The PMBN treatments, however, identified the Lipid A region of
E. coli as a potentially useful site for genetic modifications targeting increased
permeability to hydrophilic molecules like nitrocefin. More importantly, the results
presented here suggest that the genetic modification of Lipid A might be a better strategy
than reducing the Lipid A content of the cell membrane.

CHAPTER 3
Lipoprotein Mutation Accelerates Substrate-Permeability Limited Toluene
Dioxygenase–Catalyzed Reaction

One of the major problems in whole-cell biocatalysis is its low reaction rate. The
underlying cause is the substrate permeation barrier presented by cell envelopes. The
present research investigates mutation effects of the Braun’s lipoprotein, the most
abundant outer membrane structural protein in E. coli, on toluene dioxyengase (TDO)catalyzed reaction. Dramatic enhancement of the reaction rate, an increase of up to six
fold, was observed with the mutant for all three small, hydrophobic substrates tested
(toluene, ethylbenzene and 2-indanone). The increase was observed over a wide range of
substrate concentrations (0.1–5 mM). The mutant exhibited the same growth rate and
comparable recombinant multi-component enzyme expression level as the isogenic parent
strain. Taken together, the lipoprotein mutant carrying a plasmid encoding TDO is a
much better whole-cell catalyst for the oxidation reaction. The beneficial effect of the
lipoprotein mutation may be general for a broad range of substrates and enzyme systems
as the mutation affects the global integrity of the cell membrane. A comparison of the
mutation effect with a common permeabilizing procedure, the EDTA treatment, further
illustrated the clear advantages of using genetic modification in cellular membrane
engineering for improved whole-cell catalysts.
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3.1 Introduction
Toluene dioxygenase (TDO) is a multi-component enzyme system that catalyzes
the dioxygenation of toluene to toluene cis-dihydrodiol. In addition to toluene, it accepts
other aromatic compounds, non-aromatic nuclei and aliphatic olefins as substrates. It
catalyzes not only dioxygenation, but also monooxygenation, desaturation, O
dealkylation, N dealkylation, sulfoxidation, and oxidative dehalogenation reactions29,
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.

Its remarkable versatility has stimulated numerous studies in recent years for potential
applications in bioremediations of recalcitrant aromatic hydrocarbons such as toluene and
related compounds, and for chiral synthon synthesis in green chemistry applications31, 32,
33, 34, 35, 36, 37

.

So far, the studies of application of TDO have been exclusively with whole-cell
catalysts. This is not surprising as the oxidation involves multiple enzyme components
reductase, ferredoxin and terminal dioxygenase, and requires cofactor NADH. It would
be too complicated if each component of the system were to be isolated and reconstituted
in vitro. However, one obstacle in applying such whole-cell biocatalysts is the limited
substrate permeability imposed by the cell envelopes, which could result in reduced
reaction rate and low productivity
Toluene is a small hydrophobic molecule. In general, the outer membrane of
gram-negative cells such as E. coli, especially the outer leaflet that consists of
lipopolysaccharides (LPS), is a formidable barrier for hydrophobic molecules. The LPS
monolayer is a highly ordered quasi-crystalline structure with very low fluidity, which
does not allow rapid diffusion of molecules. Additional rigidity of the outer membrane
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can be attributed to its interaction with the murein layer involving an outer membrane
lipoprotein, called Braun’s lipoprotein. This protein is present in some 700,000 copies per
cell, which makes it the most abundant protein in numerical sense in E. coli. About onethird of the lipoprotein molecules are covalently linked to murein and help hold the two
structures together. Mutants defective in the structural gene for this protein are fully
viable, indicating it is nonessential. However, it is possible the disruption of lipoprotein
will affect the global membrane integrity and thus may effect some changes in substrate
permeability. Indeed, our earlier studies have found that the permeability for nitrocefin
and a tetrapeptide, substrates for a β-lactamase and a protease, respectively, through the
outer membrane were increased in a mutant which was absent of a major lipoprotein.
Consequently, reaction rates catalyzed by the respective enzymes were dramatically
increased with the mutant cells38. It was not clear, though, how the mutant would fare
with smaller but very hydrophobic molecules. In this study, we examined the mutation
effect of lipoprotein on reaction rates catalyzed by TDO. Exploiting the relaxed substrate
specificity of this enzyme system, we investigated TDO catalyzed reactions with three
different substrates, toluene, ethylbenzene, and 2-indanone. To fully assess the suitability
of the mutant as a whole-cell catalyst, a comparison study of cell growth and level of
recombinant protein production was also carried out.
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3.2 Experimental

3.2.1 Reagents, bacterial strains and plasmids
All chemicals were reagent grade and used as received. Toluene, o-cresol,
ethylbenzene, 2-ethylphenol, 2-indanone, ethyl acetate, and butyl acetate were purchased
from Aldrich (St. Louis, Mo). Isopropyl-β-D-thiogalactopyranoside (IPTG) was
purchased from BioVectra (Canada). cis-(1S,2R)-Dihydroxy-3-methylcyclohexa-3,5diene (cis-toluene dihydrodiol) was purchased from CSS (Northern Ireland). Ready TrisHCl gel, Laemmli sample buffer, 2-mercaptoethanol, SDS-PAGE Low Range Molecular
Weight Standards and Coomassie Brilliant Blue R-250 stain and destain solution were
purchased from Bio-Rad (Hercules, CA).
Plasmid pDTG601, which was constructed by inserting gene todC1C2BA into
pKK223-3 for TDO expression under the control of the tac promoter, was a gift from Dr.
D. T. Gibson39. Two E. coli host strains were used in this study. E609L, in which the
gene lpp encoding Braun’s lipoprotein was disrupted by a Tn10 insertion, is designated as
the mutant. E609 was its isogenic parent and was used as the control. Strains
E609L/pDTG601 and E609/pDTG601 were constructed by transforming the host strains
with plasmid pDTG601.
3.2.2 Cell growth curve and protein expression
LB medium supplemented with appropriate antibiotics (as described below) was
used in all cultivations. The medium for plasmid-carrying strains was supplemented with
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100 µg/ml ampicillin and the medium for the mutant was additionally supplemented with
12.5 µg/ml tetracycline. For cell growth study, 100 ml of medium in a 500 ml flask was
inoculated with an overnight culture of E609L, E609, E609L/pDTG601, and
E609/pDTG601 (2% inocula). The flasks were shaken in a rotary shaker at 250 rpm at 37
o

C. Samples were taken from each culture every hour to monitor the growth pattern by

measuring optical density at 600 nm with a UV/VIS spectrophotometer (Lambda 40
Spectrometer, Perkin Elmer). For cell growth study with induction, the same medium as
described above was used and initial cultivation was carried out at 37oC until OD600
reached 0.5–0.7, when IPTG was added to a final concentration of 1 mM and the
cultivation temperature was shifted to 30 oC.
To evaluate the TDO expression levels by SDS-PAGE analysis, samples were
taken every hour for four hours after induction. Whole-cells pellets from 1 ml culture
were suspended in 100 µl 1 × SDS-PAGE sample buffer containing 2.5% 2mercaptoethanol. Samples were boiled for 5 minutes and centrifuged briefly. 5 µl of
samples and a marker were loaded into a Ready 10 % Tris-HCl gel (6.8 cm × 8.6 cm, 1.0
mm thickness). The gel was stained using Coomassie Brilliant Blue R-250 stain solution.
3.2.3 Initial velocity measurement
Ten ml of LB medium supplemented with 100 µg/ml ampicillin in a 50 ml flask
was inoculated with an overnight culture of E609L/pDTG601 or E609/pDTG601 (2%
inocula). Other cultivation and induction conditions were as described in the cell growth
studies.
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Two hours after induction, 1 ml of culture was collected in a 1.5 ml Eppendorf
tube. Cells were harvested by centrifugation at 4,000 × g for 10 minutes at 4oC and
washed once with 10 mM sodium phosphate buffer (pH 7.4). Cell pellets were collected
by centrifugation and resuspended into 0.5 ml of same sodium phosphate buffer
containing 0.4% glucose. The reaction was started by addition of substrate to a desired
final concentration. The reaction mixture in the Eppendorf tube was then sealed with
parafilm and shaken at 250 rpm at 37oC for 15 minutes for initial rate measurement. The
product of the oxidation reaction was extracted by ethyl acetate. In the case of reactions
with toluene and ethylbenzene, before subject to GC analysis, the products were
dehydrated to their respective dihydrodiol products by an acid treatment (25 µl of 2M
HCl) (Figure 3–1)40. The extract was analyzed by a Hewlett-Packard GC/MS system. All
activities were normalized by A600 to correct for small differences in cell density between
preparations.
3.2.4 Time course
The time course of the whole cell catalyzed reactions was conducted under the
same conditions as described above, except that the reaction was allowed to proceed to a
longer period of time and samples were taken from time to time to monitor the progress
of the reactions.
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3.2.5 Analytical methods
Samples as prepared above were analyzed using a Hewlett-Packard 6890 (Palo
Alto, CA) Gas Chromatograph equipped with an MSD, an autosampler, and an injector.
A HP-5MS methylpolysiloxane phase column (30 m × 0.25 mm × 0.25 µm) was used.
The temperature for the injector and the MSD was 280 oC. Column temperature profile
was according to a pre-determined program (40oC for 1 minute, first temperature gradient
to 180oC at 10 oC/min; second temperature gradient to 300oC at 25 oC/min; and holding
the final temperature for 10 minutes). The flow rate of the carrier (He) was 1 ml/min.
Under these conditions, the retention times for butyl acetate (internal standard), toluene,
o-cresol, ethylbenzene, 2-ethylphenol, 2-indanone and (S)-2-hydroxy-1-indanone were
4.46, 3.99, 7.90, 5.17, 9.17, 7.10 and 12.55 min, respectively.
3.2.6 EDTA treatment
The effect of EDTA on whole-cell catalyzed-reaction rate was studied. EDTA
was added to a cell suspension to a final concentration in the range of 0.1 to 1.0 mM. The
mixture was incubated quiescently at room temperature for 15 minutes before 2 mM
toluene was added. The reaction was carried out under the conditions as described above.
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3.3 Results
In order to evaluate the mutation effect of lipoprotein on TDO catalyzed reactions
and the suitability of lipoprotein mutant as whole-cell catalyst in bioremediation and
green chemistry applications, we used three different TDO substrates in this study,
toluene, ethylbenzene, and 2-indanone. The respective reactions and products are
illustrated in Figure 3–1. E. coli strain E609L carries a transposon mutation in an outer
membrane structural protein called Braun’s lipoprotein, and E609 is its isogenic parent
and is used here as the control. The two strains were transformed with a plasmid
pDTG601, which harbors the genes of TDO from Pseudomonas putida F1, a multicomponent system.
3.3.1 Cell growth and recombinant protein expression
One essential attribute for microbial whole-cell biocatalysts is their ability to grow
and attain high cell density. In the process of engineering a whole-cell biocatalyst, one
important consideration is to balance the need for increased permeability of substrate
with the need for the cell to maintain sufficient membrane functions and to retain the
ability for growth as much as possible. Since the membrane function is critical to cell
growth, any mutation aimed to increase the substrate permeability should be evaluated
with respect to the effect on cell growth. We therefore carried out a comparison study to
evaluate the lipoprotein mutation on cell growth.
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Figure 3–1. Oxidation reactions catalyzed by toluene dioxygenase. (A) toluene, (B)
ethylbenzene, (C) 2-indanone.

The mutant and control were grown in shaker flasks under identical conditions
except that for the mutant, the LB medium was supplemented with tetracycline in order to
apply a selective pressure for the transposon insert. As shown in Figure 3–2A, the two
strains exhibited, in the first seven hours of cultivation, an almost identical growth rate
with doubling time of 0.96 hour. After seven hours, the growth rates were reduced, but
more so with the mutant strain, resulting in a difference in cell concentrations about 10%.

The highest cell concentrations reached were 3.1 and 3.4 OD600
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for the mutant and the

control, respectively.
Similar growth behaviors were observed when cell growth studies were carried
out with the two strains carrying plasmid pDTG601 but without induction (Figure 3–2B).
The only difference observed in growth was in the last few hours of cultivation. The
highest cell concentrations reached were 2.6 and 3.0 OD600 for the mutant and the control,
respectively, both lower than what were obtained without the plasmid, reflecting the extra
burden of maintaining an 8.6 kb plasmid. The difference in cell density between the two
strains was similar with or without plasmid (0.4 versus 0.3). Therefore, the mutation
does not dramatically affect the cell’s growth yield when carrying the plasmid. However,
the mutant did not seem to be able to maintain the highest cell density obtained and there
was a decrease of OD as soon as the highest density was reached, unlike the case without
the plasmid and with the control (Figure 3–2A), suggesting that the presence of the
plasmid made the mutant cells somehow vulnerable and the cells were on the verge of
death (or lysis) at the end of the growth period.
Growth comparison was also conducted for the two strains carrying pDTG601
with inductions. As shown in Figure 3–2C, for many hours after induction, mutant cells
were able to grow at the same rate as the parent strain. This is consistent with the results
from Figure 3–2B without induction, but surprising considering that as soon as the
growth stopped, the cell death (or lysis) ensued as manifested by the decrease of the OD.
The parent strain, however, maintained the highest cell density in the stationary phase.
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Consequently, after the cessation of the growth, the difference in cell concentrations was
widened from about 0.4 at 9th hour to about 0.6 at 12th hour.
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Figure 3–2.Growth pattern of (A) E609L (▲) and E609 (■); (B) E609L/pDTG601 (▲,
without induction) and E609/pDTG601 (■, without induction); (C)
E609L/pDTG601 (▲, IPTG induction) and E609/pDTG601 (■, IPTG
induction). Error bars represent standard deviations from the mean. All data
are measured in at least three separate experiments.

Taken together, the lipoprotein mutation does not seem to affect the growth rate
even when cells are carrying a plasmid and are producing recombinant proteins.
However, the mutation apparently sensitizes the cell to conditions that are typically found
at the end of growth, or in stationary phase. We speculate that limitations of nutrients and
accumulation of waste products such as acetate may be responsible for the difference
observed at the end of the cultivation. Further study is needed to fully understand the
underlying reasons for the phenomenon observed.
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Figure 3–3. SDS-PAGE comparison of the toluene dioxygenase expression in E. coli
E609L/pDTG601 and E609/pDTG601. The cellular fractions were loaded
on the gel as follows: 1 hr induced E609L/pDTG601 (lane 1), 1 hr induced
E609/pDTG601 (lane 2), 2 hr induced E609L/pDTG601 (lane 3), 2 hr
induced E609/pDTG601 (lane 4), 3 hr induced E609L/pDTG601 (lane 5), 3
hr induced E609/pDTG601 (lane 6), 4 hr induced E609L/pDTG601 (lane
7), 4 hr induced E609/pDTG601 (lane 8).

Since engineered whole-cell catalysts with overexpression of one or more
recombinant enzymes are common in biocatalysis, another essential attribute of the
whole-cell catalyst is the ability for high level expression of recombinant proteins. For
this reason, we carried out studies to compare the expression levels of TDO for the two
strains. Samples were taken every hour after induction for four hours, and expression
levels were evaluated using SDS-page gel and Coomassie Blue stains. Figure 3–3 shows
that there is essentially no detectable difference in expression levels of TDO between the
two strains for all the samples (1–4 hours after induction) analyzed and for all
components of the TDO system. Therefore, the mutation in lipoprotein does not affect the
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expression of the multi-component TDO system. Samples taken after 4 hours exhibited
lower activities for reasons not clear to us, but this is the case for both strains and
therefore is not an effect associated with the mutation. In subsequent catalysis studies,
conditions (2 hrs after induction) that gave rise to comparable expression levels of TDO
in two strains were used.
3.3.2 Lipoprotein mutation on initial velocity
The initial velocities for the oxidation reactions catalyzed by the two recombinant
strains were measured for substrate concentrations over the range of 0.1-5 mM. As shown
in Figure 3–4A, B, and C, the mutant strain exhibited much higher initial activities for
each of three substrates and at all substrate concentrations tested, suggesting a positive
effect of mutation on increasing reaction rate. The difference in the initial velocity was
not due to the difference in expression as comparable level of expression was achieved
(as discussed earlier). Although some of the components of TDO are inner membrane
bound and some reside intracellularly, toluene, ethylbenzene, and 2-indanone are
sufficiently hydrophobic and their passage through inner membrane is not expected to be
rate-limiting. The increased initial reaction rate is therefore likely through improved outer
membrane permeability to substrates due to the mutation.
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Figure 3–4. Effect of substrate concentration on the initial degradation rate by wholecell E. coli E609L/pDTG601 (▲) and E609/pDTG601 (■). (A) toluene, (B)
ethylbenzene, (C) 2-indanone. Error bars represent standard deviations
from the mean. All data are measured in at least three separate experiments.

Over the range of toluene concentration tested, the initial rate ratios of mutant to
parent strains varied over a range of 1.5 (at 0.1 mM) to 3.9–fold (at 5 mM). The initial
velocity profile was complicated by the presence of possible substrate and/or product
inhibitions, evident from the decline of the reaction rate with the increase of the toluene
substrate concentrations (1-5 mM) for the parent strain. The mutant strain seemed to fare
better in terms of inhibition and only a slight decrease of reaction above substrate
concentration of 4 mM was evident (Figure 3–4A).
For the second substrate, ethylbenzene, the initial velocity-substrate concentration
profile was similar to that of toluene except that there was a sharp decline of enzyme
activities at high substrate concentrations for both strains. The ratio of reaction rates of
the two strains fall in the range of 1.8 (at 0.1 mM) and 6.3 (at 5 mM). The reasons for the
difference between the two substrate, with respect to possible substrate or/and product
inhibitions, were not clear, and were not investigated further as it was deemed to be
beyond the scope of this work.
For 2-indanone (Figure 3–4C), the mutant strain had a substantially higher
reaction rate than that of the parent over the entire range of concentrations examined. For
example, at substrate concentration of 5 mM, the initial reaction rate of the mutant strain
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is about 5 times of that of the parent strain. There was apparently no inhibition for this
substrate.
A departure of the enzyme kinetics from the Michaelis-Menten model was evident
from inspection of Figure 3–4 and Eadie-Hofstee plots (Figure 3–5, shown only for
toluene). This may be due to the multi-component nature of the system and the presence
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3.3.3 Time courses of TDO catalyzed reactions
Additional experiments were carried out to further evaluate the potential of the
lipoprotein mutant as whole-cell biocatalyst in bioremediation and green chemistry
applications. Time course of product formation from toluene degradation for initial
toluene concentration of 2 mM is shown in Figure 3–6. Within 2 hours, the mutant
converted 2 mM toluene to 1.5 mM product cis-dihydrodiol, which subsequently
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chemically converted to o-cresol under acidic conditions, a conversion of approximately
75%, whereas the parent strain had a conversion only about 30% and the product
concentration reached was about 0.6 mM. For reasons not clear to us, the reactions for
both strains completed within about two hours and there was no further reaction beyond
that. The observed difference in conversion and product concentration was a result of
substantial difference in the reaction rate between the two strains, reflected by the
difference in the slopes of the time course (Figure 3–6), a result consistent with the
observed faster initial velocity (Figure 3–4A) for the mutant. Substantial differences in
conversion and product concentration were also observed when different initial toluene
concentrations were used. In all concentrations tested, the mutant degraded more toluene
and achieved higher product concentrations. At an initial concentration of 1 mM toluene,
for example, nearly 100% toluene was degraded by the mutant while the parent could
only degrade about 50% (data not shown).
Similar results were obtained with other two substrates (data not shown). The
product concentration formed with the mutant cells was 2-3 times higher than that
obtained with the parent strains, a result that correlated well with the initial velocity
differences between the two strains (Figure 3–4).
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Figure 3–6. Time course of toluene degradation by whole-cell E. coli E609L/pDTG601
(solid) and E609/pDTG601 (open). Initial toluene concentration was 2 mM.
Error bars represent standard deviations from the mean. All data are
measured in at least three separate experiments.

3.3.4 EDTA Treatment versus Lipoprotein Mutation
EDTA is an effective membrane permeabilizer. It has long been used to treat
bacterial cell membranes to increase permeability 41 . It functions through chelation of
metal ions such as Ca++ and Mg++, which cross-link lipopolysaccharides, consequently
adding to the rigidity of the outer membrane. Since the LPS layer is suspected to be the
main permeability barrier to hydrophobic molecules such as toluene, removal of these
metal ions is expected to weaken the intra-molecular interaction of LPO and loosen up
the outer membrane layer, thus allowing passage of hydrophobic molecules through the
outer membrane layer at a higher rate.
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We carefully studied conditions of treatment, and under optimal conditions (0.5
mM EDTA and a treatment time of 15 minutes), pretreatment with EDTA increased
reaction rate with toluene about 23% (standard deviation 5%) for the parent strain E609
(Figure 3–7). This compares with the lipoprotein mutation that increased the reaction rate
more than two fold (Figure 3–7, Figure 3–4A), indicating the mutation in envelope
structure could be far superior to chemical treatment. Increasing EDTA concentration
higher than 0.5 mM caused a decrease of TDO activities, probably due to the removal of
the required metal cofactors for TDO (Fe++) and the destabilizing of the inner membrane.
This result further illustrates that the chemical treatment causes undesired, generalized
damaging effects that go beyond permeabilizing.
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Figure 3–7. Effect of EDTA on the permeability of E609L/pDTG601 and
E609/pDTG601. Error bars represent standard deviations from the means.
All data are measured in at least three separate experiments.

Interestingly, no increase in reaction rate by EDTA was observed for the mutant
strain. The treatment, in fact, caused a sharp decrease of TDO activities (Figure 3–7).
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This is probably due to the defect in membrane structure caused by the lipoprotein
mutation that sensitizes the cells for EDTA treatment.
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3.4 Discussion
We have demonstrated that mutation in an outer membrane structural lipoprotein
resulted in a several fold increase in the TDO-catalyzed reaction rate with the three small
hydrophobic substrates investigated. The substantial increase in reaction rate indicates
that modification of cellular membrane composition and mass transfer barrier properties
through genetic engineering could be an effective method of accelerating whole-cell
biocatalysis.
The significant acceleration of the oxidation reaction implies that the defect in
membrane structures caused by the lipoprotein mutation may be extensive. Yet
remarkably, the mutant cells grow as fast as the parent strain, even under stressful
conditions such as carrying a medium-sized plasmid and overproducing a fourcomponent recombinant enzyme system. It seems that the mutant cells were able to
compensate the defect in membrane by some unknown mechanisms. The defect may
affect the energetic state of the membrane, the proton gradient, for example. If this is true,
it is conceivable that the mutant cells can compensate the loss of proton gradient by
metabolizing more of an energy source, which would lead to a lower growth yield.
Consistent with this explanation, we observed a slightly lower growth yield for the
mutant in all three cases investigated. The mutant cells appear to be sensitive towards the
end of the growth period, indicated by the loss of its ability to maintain cell biomass and
an immediate transition to cell death phase when carrying a plasmid. The exhaustion of
an energy source, which mutant cells are relying on to maintain the membrane energetic
state and compensate the defect, could be responsible for the observed behavior at the end
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of the cultivation. If this proves to be true, some additional carbon source would be
sufficient to curb the loss of the biomass. Thus the difference in growth behavior caused
by the mutation may not be a serious obstacle in biocatalysis applications, especially
considering the difference is rather small and the gain in rate increase is substantial.
We have shown in this study that even with small molecules (molecular weight
less than 100 Daltons), the substrate permeability can severely limit the reaction rate. A
full evaluation of the permeability barrier was not possible as attempts to remove the cell
membrane barrier and reconstitution of TDO components in vitro failed to recover a
majority of the enzyme activity. However, from the dramatic acceleration by disruption
of a structural protein, the severe limitation in substrate transfer across cell membrane can
be appreciated. This common problem in whole-cell biocatalysis has been underaddressed, and we hope our research and the encouraging results we presented here will
stimulate interest in this important area.
The genetic modifications on membrane structure with lipoprotein mutation, as
shown here and in an earlier work, brought about significant increases of several fold in
the reaction rate with three enzyme systems (including simple hydrolases and a multicomponent redox enzyme system), and five substrates encompassing different sizes and
different hydrophobicities. It appears that the beneficial effect on the whole-cell catalysis
rate of the particular mutation is general.

CHAPTER 4
Outer Membrane Mutation Effects on UDP–Glucose Permeability and Whole-Cell
Catalysis Rate

In whole-cell biocatalysis, cell envelopes represent a formidable barrier for
substrates to permeate. As a result, the reaction catalyzed by the whole-cells is often
orders of magnitude slower than that of their isolated enzyme counterparts. The present
research addresses this critical issue by investigating the effects of outer membrane
mutation on UDP-glucose utilizing enzymes in whole-cell systems. Owing to the severe
limitation in substrate permeability, the wild type cells only exhibited as low as 4% of
available enzyme activities. Reducing the barriers of the outer membrane permeability
(by mutations in its structure) led to a striking acceleration (up to 14–fold) of reaction rate
in cells expressing UDP-glucose dehydrogenase. Mutations in the lipopolysaccharide
synthesis pathway or Braun’s lipoprotein are both effective. The acceleration was
dependent upon the substrate concentrations as well as the enzyme expression level. In
addition, the mutation has been demonstrated to be much more effective than the freezethaw (FT) permeabilizing method. An application of outer membrane mutants was
illustrated with the synthesis of a disaccharide (N-acetyllactosamine) from UDP-glucose.
Both reaction rate and product yield were enhanced significantly (more than two fold) in
the lipoprotein mutant, demonstrating the importance of the outer membrane permeability
barrier and the advantages of using outer membrane mutants in synthesis.
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4.1 Introduction
Whole-cell biocatalysis allows more complicated biotransformation that requires
multi-enzymes or even multi-pathways. Enzymes enclosed inside and protected by the
cell envelopes are often more stable than their isolated counterparts. Moreover, wholecells provide what is often the only economically feasible way to regenerate expensive
cofactors. However, whole-cell catalysts suffer a major problem. The cell envelopes
represent a formidable barrier for substrates to permeate. As a result, the reaction
catalyzed by the whole-cells is often orders of magnitude slower than that of the isolated
enzymes.
Until recently, the only effective way to address this was to permeabilize cells by
chemical (such as detergent, solvent, and chelators) or physical (such as extreme
temperature fluctuations) treatment. These methods are not desirable, especially for large
scale applications, since they create additional steps in manufacturing processes,
complicate downstream processing, and incur unintended damage to cells. Previously, we
demonstrated that modifications in cellular membrane structure through a molecular
engineering approach could be very effective in reducing the permeability barriers , 42.
Some benefits of this approach are that the modification to the cell membrane structure is
localized and effects on cell growth are minimal.
In this chapter, we report a permeability study of a relatively large and
hydrophilic molecule, UDP-glucose, using E. coli cells that express recombinant UDPglucose utilizing enzymes. The results reveal a severe limitation in permeability for this
molecule and a striking acceleration of reactions by single mutations in membrane
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structure. Also, the application of these mutants is illustrated with the synthesis of a
important disaccharide, N-acetyllactosamine (LacNAc). LacNAc is one of the most
common core structures in oligosaccharides of glycoproteins, some of which are
significantly elevated in various types of cancer patients 43 , 44 . LacNAc also play an
important role in the initial event in many inflammatory responses45. The widespread
biological role of LacNAc-based oligosaccharides has led to an increased demand for
these structures for biomedical studies, and therefore, simple and efficient synthetic
routes to these compounds are desirable. Compared to tedious chemical approaches
(involving multiple protection and deprotection steps)46,47, the enzymatic preparation of
these structures using glycosyltransferases is highly efficient, and has been applied in
gram-scale production48. In this study, the product yield of LacNAc was increased using
membrane mutant strains. Also, important implications of the permeability issues in
whole-cell biocatalysis research are discussed.
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4.2 Experimental

4.2.1 Chemicals and reagents
All chemicals were reagent grade and used as received. UDP-glucose (UDP-Glc),
NAD, UDP-glucuronic acid (UDP-GA), N-acetyl-D-glucosamine (GlcNAc), N-acetyl-Dlactosamine (LacNAc), isopropyl-β-D-thiogalactopyranoside (IPTG), and dithiothreitol
were purchased from Sigma (St. Louis, Mo). Primers were from Invitrogen (Carlsbad,
CA). Ready Tris-HCl gel, Laemmli sample buffer, 2-mercaptoethanol, SDS-PAGE low
range molecular weight standards, Coomassie Brilliant Blue R-250 stain, and destain
solution were purchased from Bio-Rad (Hercules, CA).
4.2.2 Bacterial strains and plasmids
The E. coli strains and the plasmids used in this study are listed in Table 4–1. Two
types of E. coli membrane mutant strains were used in this study. The lipid A mutant
SM101(lpxA2) is a thermo-sensitive, UDP-N-acetylglucosamine acyltransferase (lpxA)
defective strain49. SM105 is its isogenic parent strain. E609L carries a Tn10 insertion in
lpp coding for Braun’s lipoprotein. E609 is its isogenic parent.
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Table 4–1. E. coli strains and plasmids used in this study.
Strain or Plasmid
E. coli strains
SM101

Description

Reference

SM105
E609L

lpxA2 mutant, thermosensitive, grows well at
28oC
lpx A2+, isogenic parent of SM101
lpp::Tn10; periplasmic leaky; Tcr

,
49,
,

E609
E609L(∆lacZ)
E609(∆lacZ)

HfrC pps, isogenic parent of E609L
E609L with deleted lacZ gene on chromosome
E609 with deleted lacZ gene on chromosome

18,
This study
This study

E.coli O12:K5(L)
Plasmids
pCW-lgtB

ATCC 23508

pLysTE7
pGEM-T-Easy
vector
pQE80L
pBBR122
pT-GalE
pT-LgtB
pT-EL
pQEL
pT-KfiD
pQEkfiD
pCEL
pKD13
pKD46
pCP20

ampr, containing β-1,4-galactosyltransferase
gene
ampr, containing E. coli UDP–galactose 4epimerase.
ampr
commercial expression vector from Qiagen
containing T5 promoter and lacIq
gram negative broad host vector
containing galE gene with Bgl II, Bam H I site
lgtB gene containing Bam H I and XhoI sites
ampr containing galE:lgtB with Bgl II XhoI
sites
ampr with T5 drive galE:lgtB fusion expression
ampr, containing KfiD gene
UDP-glucose dehydrogenase gene kfiD in
pQE80L
T5 directed β-1,4-galactosyltransferase
(lgtB)/UDP-galactose 4-epimerase (galE)
fusion protein encoding plasmid
template plasmid
phage λ Red recombinase helper plasmid
FLP recombinase elimination helper plasmid

ATCC
50
51
Promega
Qiagen
MoBiTech
This study
This study
This study
This study
This study
This study
This study
52
52
52
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4.2.3 Construction of lacZ knockout strains
The strains E609L(∆lacZ) and E609(∆lacZ) were constructed for LacNAc
production using the gene inactivation method developed by Wanner and coworkers52.
The FRT-flanked kanamycin resistance gene was PCR amplified along with a 50–
nucleotide extension at each end, which is homologous to the adjacent regions of the
genomic lacZ gene. The PCR product was generated using plasmid pKD13 as the
template

and

the

following

primers:

the

5’

primer,

5’-

GCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCGT
GTAGGCTGGAGCTGCTTC-3’)

and

the

3’

primer,

5’-

TTAAATAGTACATAATGGATTTCCTTACGCGAAATACGGGCAGACATGGCAT
TCCGGGGATCCGTCGACC-3’ (homologous regions underlined). Subsequently, the
purified PCR product was introduced by electroporation into the target strains E609L and
E609, which were carrying Red helper plasmid pKD46. Homologous recombination
mediated by the plasmid-borne (pKD46) phage λ Red recombinase resulted in kanamycin
resistant transformants. The kanamycin gene was then excised by introducing the FLP
helper plasmid, pCP20, harboring the gene for FLP recombinase. Finally, both the Red
helper plasmid and the FLP helper plasmid were cured by growth at above 37°C as they
contain temperature-sensitive replicons.
4.2.4 Construction of pQEkfiD, a T5 driven KfiD expression vector
The UDP-glucose dehydrogenase gene, kfiD53, was amplified from the genomic
DNA of E. coli O12:K5(L) (ATCC 23508) with the primers designed according to the

kfiD

sequence

(GenBank

accession

#:

X77617).

The

5’

primer

63
(5'-

TGGAGATCTATGTTCGGAACACTAAAAATAACTG-3') is a 34-mer that includes a
Bgl II site (bold italics) and ATG start codon (bold underlined). The 3’ primer (5'TTCTCGAGTTAGTCACATTTAAACAAATCGCGAC-3') is also a 34-mer with a Xho
I site (bold italics) and stop codon TAA (shown its reverse complementary sequence,
underlined). The 1.1 kb fragment was first inserted into the pGEM T-easy vector
(Promega) to give pT-kfiD. Then the final expression vector pQEkfiD was constructed by
inserting the kfiD gene, obtained from pT-kfiD by the double digestion by Bgl II and Xho
I, into the BamHI and SalI site of pQE80L (Qiagen). The organization of the plasmid
pQEkfiD is shown in Figure 3–1A.
4.2.5 Construction of pCEL, a T5 driven galE: lgtB fusion expression vector
The E. coli UDP-galactose 4’-epimerase gene was amplified from pLysPTE7
using

the

following

primers.

The

5’

primer,

5'-

TGGAGATCTATGAGAGTTCTGGTTACCGGTGGT-3’, contains a Bgl II site (in bold
italics)

and

start

codon,

ATG

(underlined);

the

3’

primer,

(5'-

TAGGATCCGCCAGCGCTGAATCGGGATATCCCTGTGGATG-3’) contains a BamHI
site (shown in bold italics) with the original stop codon, TAA, mutated to Ser codon
TCA, (reverse complementary sequence underlined) and a mini-linker sequence, coding
for a linker peptide, Ala-Ala-Gly-Gly-Ser. The PCR fragment, about 1 kb, was ligated
into the pGEM T-easy vector to give the plasmid pT-GalE. The gene for β-1,4galactosyltransferase from Neisseria meningitidis, was cloned from a plasmid pCW-lgtB

with

the

following

primers.

The

5’

primer,
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(5'-

TAGGATCCATGCAAAACCACGTTATCAGCTTAG-3’), contains a BamHI site (bold
italics)

and

start

codon

ATG

(underlined);

the

3’

primer,

(5'-

TACTCGAGTTATTGGAAAGGCACAATGAACTG-3'), contains an Xho I site (bold
italics). The amplified PCR fragment (about 0.8 kb) was inserted into the pGEM T-easy
vector to give the plasmid pT-lgtB. The lgtB gene fragment, obtained from pT-LgtB by
the double digestion by BamHI and SacII, was inserted into the same sites in pT-GalE
downstream from galE to give pT-EL. The fusion gene fragment obtained by Bgl II and
Xho I digestion was fused into the BamHI and SalI sites of pQE80L to give pQEL. The
plasmid pCEL was obtained by inserting the entire XhoI-hydrolyzed broad range host
plasmid pBBR122 into the XhoI site of the pQEL. The organization of the plasmid pCEL
is shown in Figure 3–1B.
4.2.6 Expression of UDP-glucose dehydrogenase and GalE-LgtB fusion protein in E.
coli
The LB medium supplemented with appropriate antibiotics (as described below)
was used in all cultivations. The medium for pQEkfiD carrying strains was supplemented
with 100 µg/ml ampicillin and the medium for pCEL carrying strains was supplemented
with 100 µg/ml ampicillin and 25 µg/ml chloramphenicol. All medium for the E609L and
E609L(∆lacZ) strains were additionally supplemented with 12.5 µg/ml tetracycline, due
to the Tn10 insertional mutation of the lpp gene.
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A

BB

xho I Eco R I

Amp R

Pst I
Hind III
Nde I

kfiD

Xba I
ColE1

Apa I

pQEkfiD
5452bp
IacIq

Nco I

Xba I

Xba I
Nco I

pCEL
12 Kb

IacIq

Nde I

GalE:LgtB T5

ColE1
Eco R I

Xba I

pBBR

T5

AmpR

Xho I

Bam HI
Nco I

Xho I

Apa I

Figure 4–1. Plasmid map of pQEkfiD(A) and pCEL (B). Abbreviations are as follows:
AmpR: ampicillin resistance gene; ColE1: colE1 origin of replication;
galE:lgtB: fusion gene of UDP-galactose-4-epimerase and β-1,4galactasyltransferase; kfiD: UDP-glucose dehydrogenase gene, lacIq: LacIq
repressor; T5: phage T5 promoter; pBRR: Broad-Host-Range Vectors
pBBR122 (MoBiTec).

For the expression of UDP-glucose dehydrogenase, 10 ml of LB medium in a 50
ml flask was inoculated with an overnight culture of SM101/pQEkfiD, SM105/pQEkfiD,
E609L/pQEkfiD, and E609/pQEkfiD (2% inocula). Cells were grown at 28oC with
shaking at 250 rpm. IPTG was added to a final concentration of 1 mM when OD600
reached 0.5~0.7 and the cells were incubated for additional four hours at 28 oC. Cells
were then collected for further analysis. For the study with different IPTG induction
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concentrations, the cultivation was conducted under the same conditions as described
above, except that different IPTG concentrations were added.
For the expression of GalE-LgtB fusion protein, 100 ml of LB medium in a 500
ml flask was inoculated with an overnight culture of E609L(∆lacZ)/pCEL and
E609(∆lacZ)/pCEL and incubated at 30oC until OD600 reached 0.2~0.3, upon which IPTG
was added to a final concentration of 1 mM. After induction, the cultivation was
continued for another four hours at a lower temperature (25 oC).
4.2.7 UDP-glucose dehydrogenase activity assay
4.2.7.1 Whole cell activity assay
Cultivation and induction conditions were as described in section 4.2.6. 0.5 ml of
induced culture was collected in a 1.5 ml Eppendorf tube. Cells were harvested by
centrifugation at 4,000 × g for 10 minutes at 4oC and washed once with 100 mM TrisHCl buffer (pH 9.0). Cell pellets were collected by centrifugation and resuspended into
0.5 ml of same Tris-HCl buffer. The reaction was started by the addition of substrates,
UDP-Glc and NAD+, to desired final concentrations. Samples were taken during the first
30 minutes of the reaction at 37oC to measure the initial rate. The reaction was terminated
by centrifugation at 13,000g for 5 minutes and the supernatant was subjected to an HPLC
analysis (Hewlett-Packard 1100 Series). All activities were normalized by A600 to correct
for small differences in cell density between preparations.
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4.2.7.2 Cell extract activity assay
The cell extract was prepared by removing cell envelopes using Bugbuster
(Novagen, San Diego, CA) and lysozyme. Cell pellets were suspended in Bugbuster with
20 µg/ml lysozyme, upon which they were incubated at 10oC and 250 rpm for 60
minutes, followed by centrifugation at 13000 × g for 15 minutes at 4 oC. The supernatant
was then analyzed for enzyme activity. The UDP-glucose dehydrogenase activity of cell
extract was assayed spectrophotometrically by following the reduction of NAD+ at 340
nm, using a UV/VIS spectrophotometer (Lambda 40 Spectrometer, Perkin Elmer). The
reaction mixture contained 1 mM UDP-Glc, 2 mM NAD+, 2 mM dithiothreitol, 50 µl of
cell extract, and 100 mM Tris-HCl buffer (pH 9.0) for a total volume of 1 ml. The
reaction was initiated by the addition of the cell extract. The initial velocity of the NAD+
reduction (ε340 = 6,220 M–1cm–1) was measured during the first minute. The whole-cell
activity assay and cell extract assay were compared and found to be consistent with each
other.
4.2.8 Freeze-thaw treatment
The effect of freeze-thaw on the whole-cell catalyzed-reaction rate was also
studied. Cell pellets were frozen at -80oC for 30 minutes and thawed at room temperature.
The reaction was then carried out under the conditions as described above.
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4.2.9 Cell extract activity assay for GalE-LgtB fusion enzyme
The GalE-LgtB fusion protein activity assay was conducted at 37oC in 100 mM
pH 7.5 Tris-HCl buffer (0.5 ml final volume), which contained 5 mM UDP-Glc, 10 mM
GlcNAc, 10 mM MnCl2, 1% bovine serum albumin and 0.44 ml cell extract. Cell extract
was prepared as described in section 4.2.7.2 for UDP-glucose dehydrogenase. The
reaction was terminated after 15 minutes by boiling the reaction mixture for 5 minutes.
The precipitates were then removed by centrifugation at 13,000g for 5 minutes. The
product of the reaction, LacNAc, in the supernatant, was analyzed by a Dionex BioLC
system. One unit of GalE-LgtB fusion protein activity is defined as the amount of enzyme
required to produce 1 µmol of LacNAc per minute. All activities were normalized by
A600 to correct for small differences in cell density between preparations.
4.2.10 Time course of LacNAc production
Cells from 50 ml of culture were harvested by centrifugation at 4,000 × g for 10
minutes at 4oC and washed once with 100 mM Tris-HCl buffer (pH 7.5) with 10 mM
MnCl2. Cell pellets were collected by centrifugation and resuspended into 0.5 ml of the
same buffer. The reaction was started by the addition of 10 mM UDP-Glc and 40 mM
GlcNAc. The reaction mixture was shaken at 250 rpm and 37 oC, and samples were taken
at regular intervals to monitor the progress of the reaction. Samples were centrifuged at
13,000 × g for 5 minutes and the supernatant was analyzed by a Dionex BioLC system.
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4.2.11 SDS-PAGE analysis
The expression levels of UDP-glucose dehydrogenase and GalE-LgtB Fusion
Protein were evaluated by SDS-PAGE analysis. Cell pellets were suspended in 100 µl 1 ×
SDS-PAGE sample buffer containing 2.5% 2-mercaptoethanol. The samples were boiled
for 5 minutes and centrifuged briefly. 10 µl of samples and the marker were then loaded
into a Ready 10 % Tris-HCl gel. The gel was stained using Coomassie Brilliant Blue R250 stain solution.
4.2.12 Analytical Methods
4.2.12.1 UDP-glucuronic acid assay
The samples were analyzed using a Hewlett-Packard 1100 Series HPLC system
(Palo Alto, CA) equipped with a quaternary pump and diode-array detector. A YMC
reversed-phase J’Sphere ODS column, 150 m × 4.6 mm I.D., 4 µm particle size (Waters,
Milford, MA) was used. The ion-pairing method used was described previously54.
4.2.12.2 LacNAc assay
A Dionex BioLC HPLC system (Sunnyvale, CA) equipped with a GS50 gradient
pump, ED50 electrochemical detector, and Dionex CarboPac PA10 column (4 × 250 mm)
was used. Two solvents were used as eluents: 200 mM NaOH and H2O. The HPLC
method consists of 3 steps: elution, regeneration, and equilibration. It was performed as
follows: elution: 18% 200 mM NaOH and 82% H2O for 23 minutes; regeneration: 50%
200 mM NaOH and 50% H2O for 15 minutes; equilibration: 18% 200 mM NaOH and
82% H2O for 14 minutes.
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4.3 Results

4.3.1 Mutation effects on UDP-glucose dehydrogenase activity
UDP-glucose is a relatively large molecule (molecular weight 610), close to the
maximum size allowable through porins. In addition, since it is hydrophilic, there could
be considerable mass transfer resistance in the highly hydrophobic inner leaflet of the
outer membrane, which is made of phospholipids. Mutations at the outer membrane
structures could lead to increased permeability. Two types of outer membrane mutants
were used in this study. SM101 carries a mutation in the first enzyme of the Lipid A
synthesis pathway, resulting in a reduced synthesis of LPS. E609L carries an insertional
mutation in a structural protein, Braun’s lipoprotein, which provides a covalent link
between the outer membrane and the peptidoglycans. The permeability of the membranes
was evaluated by measuring the reaction rate catalyzed by an overexpressed enzyme,
UDP-glucose dehydrogenase (Figure 4–2A). The respective parental strains were used as
controls. Figure 4–3 shows a comparison of whole-cell activities between the mutants and
the respective controls. Whole-cells carrying either type of mutation exhibited a much
higher activity than their respective parental strains, increasing reaction rate by a factor of
2.0–to–14, depending on the substrate concentrations used. Under all conditions, there
were no significant differences in the expression levels of the enzyme between the mutant
and the control. A typical SDS-PAGE gel is shown in Figure 4–4. This was further
supported by the activity measurement in the cell extracts (prepared by removing cell
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membranes) (Table 4–2). Therefore, the differences observed in the reaction rate can be
attributed to the altered rate of substrate uptake due to the mutations.
(A)
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Figure 4–2.

CH2OH
O

beta-1,4-galactosyltransferase
N-acetyl-D-glucosamine

OUDP

UDP-galactose

HO

HO

CH2OH
O

O

OH HO

CH2OH
O

NHAC

N-acetyl-D-lactosamine

OH

Reactions catalyzed by (A) UDP-glucose dehydrogenase and (B) GalELgtB fusion protein.

When whole-cell activities are compared to their cell extract activities, striking
differences are evident (Table 4–2). At a relatively low substrate concentration (5 mM),
the whole-cell activities for the parental strains only represent a small fraction of total
activity inside the cells, about 4% for both E609 and for SM105, suggesting that severe
permeability limitations imposed by the cell membranes. The mutations at the outer
membrane structure dramatically increased the whole-cell activity, 9–fold for SM101 and
14–fold for E609L, bringing it to about 34% of the cell extract level for SM101 and 60%
for E609L. At a higher substrate concentration (20 mM), the LPS mutant recovered about
73% of the activity, compared to about 19% with the parental strain. The lipoprotein
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mutant recovered nearly 100% of the cell extract activity whereas only about 10 %
activity was exhibited by the control strain. The results indicate that mutations at the
outer membrane structures were effective in reducing the substrate permeability barrier in
whole-cell catalysts. The lipoprotein mutation seemed to be particularly effective,
capable of eliminating the permeability barrier under certain conditions.
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Figure 4–3. The effect of substrate concentrations on the initial rate of whole-cell E.
coli SM101/pQEkfiD (S), SM105/pQEkfiD (U), E609L/pQEkfiD ()
and E609/pQEkfiD ( ). 2 mM NAD+ was used in all reactions. Error bars
represent standard deviations from the mean. All data are measured in at
least three separate experiments.
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SDS-PAGE analysis of the UDP-glucose dehydrogenase expression in E.
coli strains: SM101/pQEkfiD, SM105/pQEkfiD, E609L/pQEkfiD and
E609/pQEkfiD. The cellular fractions were loaded on the gel as follows:
marker (lane 1), 4 hr induced SM101/pQEkfiD (lane 2), 4 hr induced
SM105/pQEkfiD (lane 3), 4 hr induced E609L/pQEkfiD (lane 4), 4 hr
induced E609/pQEkfiD (lane 5).

Table 4–2.

A comparison of UDP-glucose dehydrogenase activity in whole-cell and
cell extract of SM101/pQEkfiD, SM105/pQEkfiD, E609L/pQEkfiD and
E609/pQEkfiD
Activitya (mUnits/1 ml 1.0OD600 cell)

Cell extract
Whole cell
Whole cell/Cell extract (%)
Whole cell
Whole cell/Cell extract (%)

SM101
43.0 ± 2.2

SM105
E609L
E609
39.9 ± 0.4
49.5 ± 1.6
51.7 ± 5.7
At 5 mM Substrate Concentration
14.7 ± 1.7
1.6 ± 0.1
29.5 ± 2.6
2.1 ± 0.2
34.2
4.0
59.6
4.1
At 20 mM Substrate Concentration
31.4 ± 0.9
7.4 ± 0.7
48.8 ± 6.5
4.9 ± 1.1
73.0
18.5
98.6
9.5
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All activities are measured in at least three separate experiments and expressed as means

a

± 1 standard deviation.

4.3.2 Enzyme expression levels on whole cell activities
It is nowadays a common practice to use whole cells, overexpressing one or more
enzymes, as catalysts. Often in these systems, the inducer concentration is used to
modulate their activities. Higher activities usually correlate with higher expression levels.
Although this is true in most cases with activities measured in cell extracts, in whole-cell
system, if substrate permeability is a problem, the relation between the inducer
concentration, the expression level, and the enzyme activity can be more complicated.
Table 4–3 illustrates how the enzyme activity responds to the inducer concentrations. For
E609, in the cell extract, the activity increased from about 2 mU to about 50 mU, a 25–
fold difference, when IPTG concentrations jumped from 0.01 mM to 1 mM. However,
the whole-cell activity did not respond to the increase of IPTG nearly as dramatically,
increasing the activity only 7 times for the same inducer concentration change. Clearly,
the substrate permeability limitation diminished the cell’s gain from increased inducer
concentrations. The mutant strain, E609L, which allowed the substrate greater
permeability, was more sensitive to IPTG concentration change. The enzyme activity
jumped about 11 times (Table 4–3). This result indicates that substrate permeability is an
important (yet often overlooked) factor that needs to be taken into account in the
construction of recombinant whole-cell catalysts.

Table 4–3.
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UDP-glucose dehydrogenase activity of whole-cell and cell extract of
E609L/pQEkfiD and E609/pQEkfiD at different IPTG concentrations.

Conc. of IPTG (mM)
E609L
E609

Whole Cell Activity (mUnits)/1 ml 1.0 OD600 Cella
0.01
0.1
0.5
1
2.6 ± 0.4
20.5 ± 3.5
27.8 ± 1.7
29.5 ± 2.6
0.3 ± 0
1.8 ± 0.3
2.3 ± 0.1
2.1 ± 0.2

Conc. of IPTG (mM)
E609L
E609

Cell Extract Activity (mUnits)/1 ml 1.0 OD600 Cell
0.01
0.1
0.5
1
1.6 ± 0.3
32.6 ± 0.3
44.2 ± 1.6
49.5 ± 1.6
1.9 ± 0.1
33.2 ± 5.0
46.5 ± 1.4
51.7 ± 5.7

a

The whole cell activity was measured with 5 mM UDP-Glc and 5 mM NAD+ as

described in Materials and Methods. All activities are measured in at least three separate
experiments and expressed as means ± 1 standard deviation.
Interestingly, as the mutant E609L is more responsive to IPTG concentration than
E609, the activity ratio of E609L to E609 increased with the increase of the inducer
concentration (Figure 4–5), with more pronounced effects observed at lower IPTG
concentrations (0.01–0.1 mM). The beneficial effects of outer membrane mutation,
therefore, depend on the expression levels.
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Figure 4–5. The effect of different IPTG concentrations on the whole-cell activity ratio
of E609L/pQEkfiD to E609/pQEkfiD. 5 mM UDP-Glc and 5 mM NAD+
were used in all reactions. Error bars represent standard deviations from the
mean. All activities are measured in at least three separate experiments.

4.3.3 Mutation versus freeze-thaw
The effectiveness of outer membrane mutation in reducing substrate permeability
limitations was compared to a common permeabilization procedure, freeze-thaw (FT),
known to be effective in permeabilizing cell membranes for UDP-glucose55. Figure 4–6
shows that mutation of the LPS synthesis pathway is much more effective, increasing the
whole-cell activity by about 9 times versus 2 times with FT. Similarly, the lipoprotein
mutation led to an increase of nearly 14–fold, compared to about 5–fold with FT. Besides
being more effective, the genetic engineering approach eliminates the need for additional
processing steps, time, and equipment. Therefore, modification of the outer membrane is
far superior to FT treatment.
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Figure 4–6. A comparison of membrane mutation and freeze-thaw method. 5 mM UDPGlc and 5 mM NAD+ were used in all reactions. Error bars represent
standard deviations from the mean. All data are measured in at least three
separate experiments.

4.3.4 LacNAc synthesis from UDP-glucose
As an example of the application of outer membrane mutants in synthesis, we
studied the LacNAc synthesis from UDP-glucose. LacNAc is one of the most common
core structures in glycans, some of which are significantly elevated in various types of
cancer patients56. Its synthesis from UDP-glucose is of particular interest as UDP-glucose
is 100 times less expensive than UDP-galactose , . To achieve high synthesis with wholecell catalysts, host modification is necessary to remove the β-galactosidase activity,
which hydrolyzes the product. This was done by knocking out the β-galactosidase
encoding gene (lacZ) from the chromosome of E609 and E609L. A PCR-based gene-
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knockout method was used. The resulting knockouts were verified by gene sequencing
and activity assay (data not shown). The two required enzymes, UDP-galactose 4’epimerase (galE, catalyzing the reversible conversion between UDP-glucose to UDPgalactose) and a β-1, 4-galactosyltransferase (lgtB, catalyzing the addition of a galactose
from UDP-galactose in beta 1 to 4 linkage to N-acetylglucosamine to yield LacNAc),
were introduced as a fusion (Figure 4–1B; Detailed construction of the plasmid is given
in the section 4.2.5). The reaction yielding LacNAc is shown in Figure 4–2B.
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Figure 4–7. The time course of LacNAc production by whole-cell E609L(∆lacZ)/pCEL
() and E609(∆lacZ)/pCEL ( ). 10 mM UDP-Glc and 40 mM GlcNAc
were used in the reaction. Error bars represent standard deviations from the
mean. All data are measured in at least three separate experiments.

Figure 4–7 is a comparison between E609L(∆lacZ)/pCEL and E609(∆lacZ)/pCEL
in the synthesis of LacNAc. The initial rate of synthesis was about 2.5 times higher for
the lipoprotein mutant. In addition, there were substantial differences in product yields.
Under the same conditions, the mutant gave a product yield of 100% (based on the input
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of UDP-glucose), whereas the parental strain gave only 50% yield. This difference may
be due to the product inhibition by UDP, which was found to have accumulated in the
parental strain (data not shown). The accelerated reaction rate can be attributed to the
increased permeability resulting from the lipoprotein mutation, as there was no
significance difference in the expression levels of the two strains (Figure 4–8).
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Figure 4–8. SDS-PAGE analysis of the GalE-LgtB fusion protein expression in E. coli
E609L(∆lacZ)/pCEL and E609(∆lacZ)/pCEL. The cellular fractions were
loaded on the gel as follows: 4 hr induced E609L(∆lacZ)/pCEL (lane 1), 4
hr induced E609(∆lacZ)/pCEL (lane 2), marker (lane 3).
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4.4 Discussion
This study demonstrates that UDP-glucose, as a large hydrophilic molecule, has
severe limitations of permeability in the outer membrane. At 5 mM substrate
concentration, only a small percentage (4%) of the possible enzyme activities was
exhibited in a whole-cell system. Modifications of the outer membrane structure are
effective in reducing these limitations as shown by the dramatically increased rate of
reactions (up to 14–fold) in the mutants. In particular, nearly 100 % of the available
enzyme activity (in cell extracts) was recovered in cells with the lipoprotein mutation at
20 mM substrate concentration. The gains of the mutation in reaction rate are the result of
increased intracellular substrate concentrations, which can be illustrated with the
following analysis. We assume that the simple Michaelis-Menten kinetics applies to the
UDP-glucose dehydrogenase, and Km value for UDP-glucose is 0.015 mM57, and Vmax
measured in this study are 41.5 mU for SM105 and SM101, and 50 mU for E609 and
E609L. The intracellular concentrations of UDP-glucose in the whole cells were
estimated using this model. They are tabulated in Table 4–4. The intracellular substrate
concentrations for wild-type cells are 3–4 orders of magnitude lower than the
extracellular concentration. This is consistent with the general observation that the wholecell catalyzed rate is usually orders of magnitude lower than of the isolated enzyme
counterpart. Mutations at the outer membrane increase the intracellular concentration by
10–to–380–fold (Table 4-4). The mutations coupled with increased extracellular substrate
concentration raised the level of intracellular substrate concentration 3–to–40–fold above
the Km value; consequently, whole cells exhibited almost the maximum activity. It is
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important to note that a substrate concentration of 5 mM is 330–fold higher than the Km
value. Supplying a substrate at this high concentration allows the reaction to proceed at
approximately two orders of magnitude (instead of four orders of magnitude as predicted
from the intracellular concentration) lower than the isolated enzyme counterpart. If the
substrate concentrations was not supplied that high, the whole cell activity could well fall
below the detection level. This could lead to erroneous conclusions in biocatalyst
screening and development. This model analysis depicts a drastically different
environment that an enzyme experiences intracellularly and illustrates, once again, the
need and the importance to evaluate substrate permeability in whole-cell biocatalysis
research.

Table 4–4. Intracellular UDP-glucose concentration estimated using the MichaelisMenten Model.

Intracellular Concentration
Ratio: Extracellular to Intracellular
Ratio: Mutant to Parent
Ratio: Concentration to Km
Intracellular Concentration
Ratio: Extracellular to Intracellular
Ratio: Mutant to Parent
Ratio: Concentration to Km

Modeled Intracellular Concentration (µM)
SM101
SM105
E609L
E609
At 5 mM Extracellular Concentration
8.23
0.60
21.59
0.66
608
8313
232
7603
13.68
30.82
0.55
0.04
1.44
0.04
At 20 mM Extracellular Concentration
46.63
3.26
610.00
1.63
429
6144
33
12272
14.33
374.30
3.11
0.22
40.67
0.11

The enzymes investigated, UDP-glucose dehydrogenase and the epimerasegalactosyltransferase fusion, were both over-expressed in the cytoplasm. As the inner
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membrane is highly hydrophobic, it is expected that the molecule also experiences
limitations in the penetration of the inner membrane. This may be reflected by the fact
that even with substantial outer membrane permeabilizing, only up to 60% of the activity
was recovered at 5 mM substrate concentration. Only at a much higher substrate
concentration (20 mM) was 100% activity recovery achieved. Our current system does
not allow an assessment of the inner membrane permeability. As a matter of fact, our
initial efforts in isolating the outer membrane permeability from inner membrane
permeability (by expressing these enzymes in periplasmic space) resulted in either
inactive enzymes or very low level expression, not conducive to the permeability study.
Nevertheless, the significant rate acceleration achieved by mutations on the outer
membrane structure suggests that the outer membrane permeability barrier for this
molecule is significant and substantial reduction could be achieved through membrane
engineering. If inner membrane permeability can be addressed, the maximum activity
could be reached at an external substrate concentration lower than 20 mM.
This, along with our earlier work , , indicates that the beneficial effects of outer
membrane mutation seem to be universal to all six molecules investigated. However, the
gains in rate acceleration due to mutations varies from a mere 120%–to–1400%, and
appears to be dependent, in a complicated manner, on the molecular structures of the
substrate molecules (such as size and hydrophobicity), and the exact nature and locations
of the mutation. This warrants further investigation. Finding a correlation of mutational
effects to the molecular features of substrates will allow membrane structures to be
tailored for specific process needs. The gains, as illustrated in this work, are also
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dependent on the enzyme expression levels and substrate concentrations. Other
conditions that influence enzyme reaction rates such as pH and temperature could also
affect the rate accelerations, which await further studies.
The severe limitations of substrate permeability on whole-cell reaction rates, as
revealed in this paper, as well as our earlier work and that of others –7,

, , , 58, 59

, clearly

demonstrates a need for an assessment of membrane permeability in biocatalysis research
and development. The dramatic improvement in the reaction rate with outer membrane
mutants testifies to the effectiveness of using a molecular engineering approach to
address this permeability problem. Although so far our work has been done exclusively
with substrates, permeability problems with products produced and accumulated
intracellularly could conceivably be addressed using the same membrane engineering
strategies as illustrated in this work.

CHAPTER 5
Significance and Application of lpp Lipoprotein Mutation in Whole-cell Biocatalysis

Our previous studies with a Braun’s lipoprotein mutant E609L demonstrated that
lipoprotein mutation in outer membrane could be an effective method to increase
permeability of a variety of substrates38, , 60. The results showed that reactions with all six
substrates were dramatically accelerated by this lipoprotein mutation (up to 14–fold
increase in reaction rate). In order to establish this as a generally applicable methodology
for accelerating whole-cell biocatalysis, we decided to investigate an alternative genetic
modification to obtain the same phenotype. The lpp gene deletion was successfully
introduced into E. coli strains from different genetic background and the resulted strains
were characterized. It showed that the deletion had the same effect on substrate
permeability as the original transposon mutation. Also, the lpp deletion was found to have
no significant effect on cell growth, carbon metabolism, and lipid compositions. An
example was illustrated with L-carnitine production by introducing lpp deletion into the
E. coli O44K74 strain to achieve a higher product yield. This method might be generally
applicable to biocatalysis processes as the permeability change effected by the mutation
is of global nature. These results demonstrate that a useful phenotype can now be
transferred to any E. coli strain with a straightforward genetic manipulation to effectively
enhance the rate of a whole-cell biocatalysis reaction.
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5.1 Introduction
The increasing environmental and economic pressure in past decade has
stimulated tremendous progress in the use of enzymes and microorganisms for the
production of fine chemicals, pharmaceuticals as well as food ingredient. Biocatalysis has
developed from a niche technology to a widely used manufacturing method. In many
cases, especially in large scale applications, whole-cell biocatalysts are preferred to free
enzymes. First, the isolation and purification of enzymes not only significantly increase
the cost but also might render full or partial loss of activity, while the use of whole cells
don’t have these problems. Also, the whole-cell system allows the cascades of enzyme
reactions involve multiple enzymes, cofactors and substrates , . However a major obstacle
in the application of whole-cell biocatalysts is the limited reaction rate and yield due to
the formidable permeability barrier imposed by cell envelope.
Our previous studies with a Braun’s lipoprotein mutant E609L demonstrated that
genetic modification in outer membrane could be an effective method to increase the
reaction rate by reducing the substrate permeability barrier. It showed that reactions with
all six substrates were dramatically accelerated by this lipoprotein mutation (up to 14–
fold increase in reaction rate). The lipoprotein mutation was proven to be effective
towards substrates with various size and hydrophobicity. Additionally, the lipoprotein
mutation has essentially no effect on its growth and high level expression of recombinant
protein38, , . The extraordinary performance of the lipoprotein mutant E609L suggests that
it would be of great interest to apply this as a generally methodology for accelerating
whole-cell biocatalysis. The sequence result of E609L suggests that the lpp gene is
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completely inactivated by an transposonal insertion containing multiple stop codon.
Consequently, the same phenotype could be obtained by introduction of lpp gene deletion
into strains with different genetic background. The resulted lpp deletion strain showed the
same effect on substrate permeability as the original transposon mutant E609L. Further,
the lpp deletion had no significant effect on cell growth, carbon metabolism and lipid
compositions. The result indicates that the lpp deletion could be established as a general
method for accelerating whole-cell biocatalysis.
An application was illustrated with L-carnitine production. L-carnitine [R-(-)-3hydroxy-4-trimethylaminobutyrate] is essential for the transport of long-chain fatty acids
through the inner mitochondrial membrane in eukaryotes. With the identification of its
clinical and biotechnological importance, the demand for L-carnitine has increased
worldwide. Several chemical and biological processes have been developed for its
synthesis 61 . Compared to the racemic carnitine product from chemical process,
biotransformation converts achiral precursors, such as crotonobetaine to optical purity Lcarnitine, which is safe to be administered to the patients. E. coli O44K74 has a
significantly higher carnitine dehydratase than other E. coli strains and has been
employed in the production of L-carnitine ,

, ,

. However, the biotransformation process

using whole cells resulted in a maximum of only 30–43% conversion ratio due to
unfavorable reaction equilibrium, limitations in transport system and side product
formation 62 , 63 (as depicted in Figure 5–1). Permeabilization by either detergents or
polyethylenimine to achieve higher yield of L-carnitine was reported64. But the chemical
treatment is far from being desirable, especially for large scale applications, since they

87
are usually non-specific and incur unintended damage to cell (even lysis), and also
complicate the downstream process. In this study, the lipoprotein mutation was
successfully introduced into L-carnitine production strain E. coli O44K74 by deleting the
lipoprotein encoding gene lpp using a straightforward and efficient PCR-based method.
The results showed that higher product yield of L-carnitine synthesis was achieved by lpp
deletion strain due to its increased outer membrane permeability. The faster export of Lcarnitine by the mutant cells allowed the reversible reaction catalyzed by carnitine
dehydratase to continue in a favorable direction and the product to escape from the
degradation by side reactions (Figure 5–1). These results demonstrate that a useful
phenotype can now be transferred into any E. coli strain to effectively enhance the rate of
a whole-cell biocatalysis reaction.
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5.2 Experimental

5.2.1 Chemicals and reagents
All chemicals were reagent grade and used as received. Methyl esters of
myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid (C16:1) and cis-vaccenic
acid (C18:1), L-carnitine, Acetyl-CoA, dithiobisnitrobenzoic acid (DTNB), carnitine
acetyltransferase (CAT), and N-phenyl-1-naphthylamine (NPN) were purchased from
Sigma Chemical Co. (St. Louis, MO). Crotonobetaine was graciously provided by Dr.
Manuel Canovas , . All primers used in this study were from Invitrogen (Carlsbad, CA)
and listed in Table 5–1.

Table 5–1. List of oligonucleotide primers used in this study.
Primer sequencea

Primer
name
lpp-f

5’ -CTTTGTGTAATACTTGTAACGCTACATGGAGATTAACTCAATCTAGAGGGGTGTAGGCTGGAGCTGCTTC- 3’

lpp-r

5’ -CGTGACGCAGTAGCGGTAAACGGCAGACAAAAAAAATGGCGCACAATGTGATTCCGGGGATCCGTCGACC- 3’

lpp-up

5’ -CACTACTAACACCGCATCTG- 3’

lpp-dn

5’ -GCCATACACACTGCCAGCAG- 3’

a

Homologous regions are underlined

5.2.2 E. coli Strains
E. coli strains used in this study are shown in Table 5–2. E609L carries a Tn10
insertion in lpp coding for Braun’s lipoprotein. E609Y is the lpp knockout strain
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constructed in this study. E609 is the isogenic parent of E609L and E609Y. E. coli
O44K74, a gift from Dr. Marie-Andree Mandrand, has a significant higher carnitine
dehydratase activity and was used for L-carnitine synthesis65. E. coli O44K74Y is the lpp
knockout strain constructed using E. coli O44K74 as the parent strain.

Table 5–2. E. coli strains used in this study.
Description

Source

E609L

lpp::Tn10; periplasmic leaky; Tcr

E609Y
E609

lpp deletion strain
HfrC pps, isogenic parent of
E609L and E609Y
lpp deletion strain
Isolated from the intestine of a rat
for its higher carnitine dehydratase
activity. Isogenic parent of
O44K74Y

K. W. Miller ,
(labcin@uwyo.edu)
this study
K. W. Miller ,

O44K74Y
O44K74

this study
M-A Mandrand
(marie-andree.mandrand@insalyon.fr)

5.2.3 Construction of lpp knockout strains
The lpp knockout strain was constructed using the gene inactivation method
developed by Wanner and coworkers. Briefly, the FRT–flanked kanamycin resistance
gene was PCR amplified using primers (lpp-f and lpp-r, as shown in Table 5–1) with 50–
nucleotide extensions that are homologous to the adjacent regions of the genomic lpp
gene. Homologous recombination was mediated by the plasmid–borne phage λ Red
recombinase. The kanamycin gene was then excised by helper plasmid encoding the FLP
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recombinase. Finally, both plasmids were easily cured by growth at above 37°C as they
contain temperature-sensitive replicons.
5.2.4 Characterization of lipoprotein mutant E609Y
5.2.4.1 Growth curve
LB and M9 minimal medium were used in cultivations. M9 minimal medium
contained per liter: 6.8 g Na2HPO4; 3.0 g KH2PO4; 0.5 g NaCl; 1.0 g NH4Cl; 3.6 g
glucose; 0.50 g MgSO4·7H2O, 0.015 g CaCl2·2H2O. Other supplements included 20
amino acids at a final concentration of 40 µg/ml each. The medium for E609L was
additionally supplemented with 12.5 µg/ml tetracycline. For cell growth study, 100 ml of
medium in a 500 ml flask was inoculated with an overnight culture of E609Y, E609L and
E609 (2% inocula). The flasks were shaken in a rotary shaker at 250 rpm at 37 oC.
Samples were taken from each culture at regular intervals to monitor the growth pattern
by measuring optical density at 600 nm with a UV/VIS spectrophotometer (Lambda 40
Spectrometer, Perkin Elmer).
5.2.4.2 Lipid extraction, fractionation and analysis
Phospholipids were extracted by the method of Bligh and Dyer, as modified by
Ames66. Briefly, stationary phase cells (500 mg wet weight) were washed with 10 mM,
pH7.4 sodium phosphate buffer and resuspended in 1.6ml of same buffer, after which 4
ml of methanol and 2 ml of chloroform were added with thorough mixing (water,
methanol and chloroform are in the proportion of 0.8:2:1, v/v). The suspension was
incubated in room temp for 2 h with periodic vortexing. The extract mixture was diluted

91
with 2 ml of chloroform followed by 2 ml of same buffer, whereupon the phase was
thoroughly mixed. After brief centrifugation, the lower chloroform phase (containing
lipids) was removed and subjected to further esterification. The lipid extracts were
esterified with 5% H2SO4 in methanol at 70oC for 2 hours. The fatty acid methyl esters
(FAMEs) were extracted with n-pentane. The pentane was removed with air stream, and
the FAMEs were dissolved in 1 ml of n-heptane for further gas chromatography-mass
spectrometry (GC/MS) analysis.
The fatty acid profile was determined with Hewlett-Packard 6890 GC coupled to
a HP5973 MSD (Palo Alto, CA). The temperature for the injector and the MSD was 280
o

C. The GC inlet was operated in the splitless mode at 230 oC. One microliter was

injected

from

a

10-µl

syringe

by

an

HP7683

autosampler.

An

HP-5MS

methylpolysiloxane phase column (30 m × 0.25 mm × 0.25 µm) was used, with helium as
carrier gas at 1 ml/min. The GC oven heated the column with a program started at 60oC
for 2 minutes, ramped at 10 oC/min to 150 oC, then ramped at 3 oC/min to 250 oC, finally
ramped at 10 oC/min to 300 oC, held for 5 minutes. Authentic FAME samples and the MS
spectrum were used to determine the retention times and identify individual fatty acids
derived from the strains. Retention times of identified FAMEs are shown in Table 5–3.
5.2.5 Application of lipoprotein mutant for L-carnitine production
5.2.5.1 Cell preparation
E. coli strains O44K74 and O44K74Y (Table 5–2) were aerobically grown in
LB medium at 30oC with 250 rpm 15 hrs to obtain the seed culture. Cells were cultivated
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in complete medium inoculated with 2 % (v/v) of overnight seed culture and incubated
for 24 hrs under anaerobic conditions at 37oC in completely filled, air-tight flasks without
stirring. The complete medium contained per liter: 20 g peptone, 12.6 g glycerol, 5 g
NaCl, 2 g fumarate, supplemented with 50 mM crotonobetaine to induce the expression
of the enzymes involved in carnitine metabolism.
5.2.5.2 Biotransformation using resting cells
Cells were harvested after overnight growth by centrifugation at 4,000 g for 15
minutes, washed twice with 35 mM potassium phosphate buffer (pH 7.5), and
resuspended to around 10 OD600 (~20 g wet cell/liter) in 60 mM potassium phosphate
buffer (pH 7.5) with 50 mM crotonobetaine. Biotransformation was carried out
aerobically at 37oC and 250 rpm shaking. Samples were taken every hour to monitor the
progress of the biotransformation.
5.2.5.3 L-carnitine analysis
L-carnitine concentration was determined enzymatically with the carnitine
acetyl transferase methods, based on a colorimetric reaction. Reaction mix included 0.3
mM DTNB, 0.06 mM Acetyl-CoA, 2.5 mM EDTA, 0.25 U CAT, and 100 µl of
appropriately diluted sample in 50 mM phosphate buffer (pH 7.5). Absorbance at 412 nm
was monitored using a UV/VIS spectrophotometer (Lambda 40 Spectrometer, Perkin
Elmer) after the reaction mixture was incubated at 30oC for 30 min. L-carnitine
production yield was determined as the percentage of L-carnitine produced over the
crotonobetaine supplied in biotransformation.
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5.3 Results

5.3.1 Sequence analysis of lpp in E609L
Braun’s lipoprotein, the major outer membrane lipoprotein encoded by lpp, is
present in some 700,000 copies per cell, which makes it the most abundant protein in
numerical sense in E. coli. About one–third of the lipoprotein molecules are covalently
linked to murein and help hold the two structures together. Therefore the rigidness of the
outer membrane can be attributed to the interaction between the lipoprotein and the
murein layer. Mutants defective in the structural gene for this protein are fully viable,
indicating it is nonessential. However, it is possible the disruption of lipoprotein will
affect the global membrane integrity and thus may effect some changes in substrate
permeability. Our previous studies ,

,

with the mutant, showed dramatically increased

permeability with various substrates, ranging from hydrophilic (e.g. nitrocefin) to
hydrophobic (e.g. tetrapeptide), small (e.g. toluene) to big molecules (e.g. UDP-glucose).
The acceleration in reaction rate due to the mutation was as high as 14 times, suggesting
the important effect of lipoprotein on membrane permeability. To have an insight into the
molecular basis behind this phenotype, and also to provide knowledge for future rationale
design of membrane mutants, the lpp region in E609L were sequenced and compared to
E609 (Fig. 5–2A). Primers lpp-up and lpp-dn (Table 5–1) were used for DNA
sequencing. As expected, a 59-bp insertion (in grey) at 17th bp of lpp was found in
E609L. Moreover, the insertion contains two double-stop codon (in bold), indicating lpp
is not expressed at all. Therefore, the absence of this major outer membrane lipoprotein is
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responsible for the strikingly increased permeability. This is the first time that the genetic
sequence information of this lipoprotein mutation was revealed. And most importantly, it
indicates that the same phenotype as transposonal mutation could be obtained by a simple
lpp deletion.

E609
E609L

ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACT-------------------ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTCTGATGAATCCCCTAATGAT
****************************************

E609
E609L

---------------------------------------GGTACTGGGCGCGGTAATCCT
TTTGATAAAAATCATTAGGGGATTCATCAGTACTAAACTGGTACTGGGCGCGGTAATCCT
*********************

E609
E609L

GGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTGA
GGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTGA
************************************************************

E609
E609L

CGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTTC
CGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTTC
************************************************************

E609
E609L

CGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGGC
CGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGGC
************************************************************

E609
E609L

TACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCAT
TACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCAT
************************************************************

Figure 5–2A. Comparison of nucleotide sequences of lpp from E609L and E609Y. Start
and stop codon are in bold. The grey part represents the 59-bp insertion
introduced by transposon.

5.3.2 Construction of lpp knockout strains
The significant effect of the lipoprotein mutation also suggests that it would be of
interest to introduce lpp knockout into strains with different genetic backgrounds and
establish this as a general method to accelerate reaction rate of whole-cell biocatalysis.
The lipoprotein mutant E609L used in earlier studies ,

,

was generated by phage
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transduction mediated transposon insertion, a time-consuming and labor-intensive
method in which tedious selection steps are involved. Here, a straightforward and highly
efficient, one-step PCR-based gene inactivation method was investigated to introduce lpp
deletion. The method leaves no antibiotic resistance gene marker, which is another
advantage over transposon insertion.

E609
O44K74
E609Y
O44K74Y

AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA
AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA
AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA
AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA
************************************************************

E609
O44K74
E609Y
O44K74Y

ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTGGTACTGGGCGCGGTAATCC
ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTGGTACTGGGCGCGGTAATCC
ACTCAATCTAGAGGG--------GTG--------TAGGCTGGAGCTG------------ACTCAATCTAGAGGG--------GTG--------TAGGCTGGAGCTG------------***************
**
** **** ***

E609
O44K74
E609Y
O44K74Y

TGGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTG
TGGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTG
-----------------------------------------------------------------------------------------------------------------------

E609
O44K74
E609Y
O44K74Y

ACGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTT
ACGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTT
---------CTTCGAA-----------------------------------------GTT
---------CTTCGAA-----------------------------------------GTT
** ***
***

E609
O44K74
E609Y
O44K74Y

CCGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGG
CCGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGG
CCTATACTT-------------------------------------TCTAGAGAATAGGA
CCTATACTT-------------------------------------TCTAGAGAATAGGA
** * *
*** ** ** * *

E609
O44K74
E609Y
O44K74Y

CTACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCA
CTACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCA
--ACTTCGAACTGCAGGTCGACGGATCCCCGGAAT-----------CACATTGTGCGCCA
--ACTTCGAACTGCAGGTCGACGGATCCCCGGAAT-----------CACATTGTGCGCCA
***
** *** **
* * *
* * *
**************

E609
O44K74
E609Y
O44K74Y

TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCACGCGTAACATATTCCCTTGCTCTGGT
TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCGCGCGTAACATATTCCCTTGCTCTGGT
TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCACGCGTAACATATTCCCTTGCTCTGGT
TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCGCGCGTAACATATTCCCTTGCTCTGGT
********************************* **************************

Figure 5–2B. Comparison of nucleotide sequences of lpp from E. coli E609, E609Y,
O44K74 and O44K74Y. Start and stop codon are in bold. Grey part
represents the 82-bp scar after the gene deletion.
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As our first application of this lpp deletion (detailed in the Experimental section),
lipoprotein mutant strains E609Y and O44K74Y were generated by deleting gene lpp
from their chromosomal DNA of their respective parent strains, E609 and O44K74. The
resulting lpp deletion strains were verified by PCR and sequencing. As shown in Fig. 5–
2B, the gene deletion leaves behind an 82–bp scar (in grey) in place of lpp.
The effect of the lpp deletion on the membrane permeability was studied with
UDP-glucose dehydrogenase catalyzed reaction utilizing UDP-glucose as substrate (as
described in Chapter 4). The result showed that the lpp deletion had the same effect on
the membrane permeability as transposon mutation in E609L, ~15–fold increase in the
reaction rate was observed.
5.3.3 Characterization of the lpp knockout strain E609Y
5.3.3.1 Growth and metabolism
As one of the essential attributes of whole-cell biocatalysts, growth ability of lpp
deletion strain E609Y was studied and compared to its parental strain E609 and the
transposon mutant, E609L. Two different media, LB and M9 minimal were used to
evaluate the growth of the mutant cells in both rich and minimal environment. As shown
in Figure 5–3A, three strains exhibited the similar growth rate in LB media with a
doubling time of about 0.7 hour. At the 8th hour of the growth, the cell density of ~3.0
OD600 was reached for three strains with the highest of ~3.2 OD600 observed for E609.
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Figure 5–3. Comparison of growth curve of E609Y( ), E609L() and E609(U). (A)
LB medium; (B) M9 minimal medium.

In M9 minimal medium (Fig. 5–3B), two lipoprotein mutants, E609Y and E609L,
exhibited the exactly same growth profile as expected. E609 showed higher growth rate
than that of the mutants throughout the growth. The doubling time is 0.95 hour and 0.8
hour for the mutants and the parent strain, respectively. The final cell density in M9 is
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~2.0 OD600, one third lower than that of LB medium. Similarly, E609 ended up with a
cell density bit higher (~0.2 OD600) than that of the mutants.
Also, the glucose consumption was monitored when cells were grown in minimal
medium under aerobic and anaerobic conditions. To our surprise, the result showed that
the glucose consumption rate of the mutant cells was exactly the same as the parent
strain, even under anaerobic condition (data not shown). It suggests that the mutant cells
are able to maintain the normal cell growth and metabolism without consuming more
carbon source. This is especially attractive in large-scale applications since no additional
cost on medium material is required.
Taken together, the lipoprotein mutant E609Y cells fare quite well in both LB and
minimal medium. The lipoprotein mutation doesn’t significantly affect the cell growth
and carbon metabolism. The slower growth rate of mutant is likely to be caused by the
involvement of more complicated metabolism in minimal medium to compensate the
membrane defect. Limitation of energy source and accumulation of waster products could
be responsible for this observation.
5.3.3.2 Fatty acid profile
The lipids of E. coli, exclusive of lipid A of lipopolysaccharide, are entirely
phospholipids, comprising 9.1% of total dry cell weight. The most common fatty acids
found in phospholipids are palmitic acid (16:0); palmitoleic acid (16:1); cis-vaccenic acid
(18:1). Modulation of fatty acid composition to ensure appropriate membrane fluidity and
rigidity is an important bacterial strategy for growth in different environment. It
reported67, 68,

69, 70

that most bacteria can maintain membrane fluidity and integrity by
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adaptation accomplished by changing membrane fatty acid chain length, branching
pattern, and unsaturation degree. Proper membrane rigidity can be achieved by increasing
longer-chain fatty acids and decreasing shorter-chain fatty acids. Cyclopropane fatty acid
was also found to be important to the rigidity of the cell membrane and it showed that
decrease of cis-9,10-methylene hexadecanoic acid (C17:cyc) resulted in increased
membrane rigidity71. These studies suggest that there is a control mechanism in E. coli
that regulates the fatty acid compositions to keep the variations in the physical properties
of the membrane phospholipids to a minimum.
In this study, we speculate that lipoprotein mutant E609Y cells is probably
subjected to the same control mechanism, that is, altering fatty acid composition to
compensate the compromised membrane integrity and rigidity. We therefore carried out a
comparison study to evaluate the effect of lipoprotein mutation on membrane fatty acid
profiles in E609 and E609Y cells. The GC-MS analysis result showed that eight major
fatty acids were found in membrane lipid extracts (Figure 5–4). In agreement with earlier
studies, C16:1, C16:0 and C18:1, are 3 of the most abundant membrane fatty acids in
both strains, constituting over 90% of total fatty acids. Other lipids including C14:0,
C15:0, C17:cyc, C17:0, C18:0 make up the rest. The changes in fatty acid compositions
of two strains were not dramatic, small but reproducible changes were noted. Compared
to E609, the levels of short-chain fatty acids (C14:0, C15:0, C16:1 and C16:0) and
cyclopropane fatty acid (C17:cyc) in E609Y were decreased for about 5% (Table 5–3).
This was accompanied by an increase of long-chain fatty acids (C17:0, C18:1 and C18:0)
(Table 5–3). Noticeably, one of the most abundant fatty acid C18:1 increased 4% in
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E609Y. Therefore, the E609Y cells could manage to balance the increased membrane
fluidity caused by lipoprotein deficiency by modulating proportions of membrane fatty
acids without significant change in their compositions.

Table 5–3. Comparison of fatty acid compositions of E609Y, E609L and E609.
Fatty acid (%)a

a

Difference

Major

Molecular

Retention

Fatty acids

weight

Time (min)

E609Y

E609

and E609

C14:0

242

18.3

3.7±0.8

5.0±0.2

-1.3

C15:0

256

20.8

2.7±0.8

2.8±1.0

-0.1

C16:1

268

23.2

23.7±1.4

23.9±2.8

-0.2

C16:0

270

23.8

38.3±1.8

40.3±1.1

-2.0

C17:cyc

282

26.0

6.7±1.8

7.6±2.1

-0.9

C17:0

284

26.4

2.0±0.8

1.3±0.3

0.7

C18:1

296

28.8

20.6±2.9

16.9±0.2

3.7

C18:0

298

29.2

2.4±0.4

2.1±0.4

0.3

between E609Y

The values represent weight percentages of total fatty acids and are expressed as means

± 1 standard deviation for three independent experiments.
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Figure 5–4. Gas chromatography of membrane fatty acids of E609Y(A) and E609(B). 1.
myristic acid (C14:0); 2. pentadecanoic acid (C15:0); 3. palmitoleic acid
(C16:1); 4. palmitic acid (C16:0); 5. cis-9,10-methylene hexadecanoic acid
(C17:cyc); 6. heptadecanoic acid (C17:0); 7. cis-vaccenic acid (C18:1); 8.
octadecanoic acid (C18:0).
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5.3.4 Biotransformation using E. coli O44K74Y resting cells
It has been reported that the biotransformation processes for L-carnitine
production (Figure 5–1) using E. coli O44K74 cells can only result in a maximum of 30–
43% yield due to unfavorable reaction equilibrium, transport limitations and side product
formation ,64. Both substrate (crotonobetaine) and product (L-carnitine) are hydrophilic
with MW of around 200. Chemical permeabilizers such as organic solvents (ethanol,
acetone and toluene), detergents (Tween 20 and Triton X-100) and polyethylenimine
were used to treat the O44K74 cells to achieve a higher yield of biotransformation.
However, chemical treatment of cells can often incur unintended damage to cells (even
lysis), and generate serious downstream problem, especially when detergent is used. Our
previous studies , , demonstrated that lpp lipoprotein mutation was extremely effective in
accelerating whole cell biocatalysis rates towards various substrates. Since the reaction
rates were decided by measuring the product concentrations outside the cells, the increase
in the reaction rates should also be attributed to the fast product export due to the
mutation. In this study, an lpp knockout strain E. coli O44K74Y was generated using a
previously reported gene inactivation method to evaluate the mutational effect on the Lcarnitine export and product yield.
5.3.4.1 Time course of L-carnitine production
Cells of lipoprotein mutant E. coli O44K74Y and O44K74 were grown under
the anaerobic conditions as described in 5.2.5.1. The biotransformation was performed
aerobically using resting cells (~20 g wet cell/liter) suspended in 60 mM potassium
phosphate supplied with 50 mM crotonobetaine. The time course of biotransformation
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process was monitored by measuring the L-carnitine concentration as shown in Figure 5–
5. The biotransformation started off quickly in the first two hours, with initial production
rates of 3.0 g l-1 h-1 and 2.7 g l-1 h-1 for mutant and parent strain, respectively. The product
concentration of the both strains increased slowly in the following four hours and reached
maximum level after overnight incubation. The L-carnitine yield for lipoprotein mutant
O44K74Y reached 56%, about 30% increase over the yield of its parent strain, 43%.
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Figure 5–5. Time course of L-carnitine production by whole-cell E. coli O44K74Y ( )
and O44K74 (U), with 50 mM initial crotonobetaine and ~20 g wet
cell/liter biomass. Error bars represent standard deviations from the mean.
All data are measured in three separate experiments.

From Figure 5–5, it is apparent that initial rates of both strains were very fast,
with around 31% and 36% yield in the first hour for parent and mutant strains,
respectively. Compared with the parent strain, the initial production rate of the mutant
strain was only about 10% higher, which indicated that the membrane mutation did not
have significant effect on permeability of hydrophilic substrate crotonobetaine and
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product L-carnitine at the beginning of the reaction. Our earlier studies showed dramatic
increases of 4– and 14–fold in the initial rates were achieved by the same lipoprotein
mutation with hydrophilic substrates, nitrocefin and UDP-glucose, respectively , .
However, this different observation with L-carnitine production is expected since both Lcarnitine and crotonobetaine are relatively small molecules (MW~200) compared with
nitrocefin and UDP-glucose (MW~600). The passage of these two small hydrophilic
molecules through the outer membrane should be comparatively faster because they are
far below the maximum size that allowable through the porin channels (600–700
Daltons).
The difference in the product concentrations between mutant and parent
increased as the biotransformation continued. The final L-carnitine concentrations of
mutant and parent strain were of 28.0 mM and 21.6 mM, respectively. Based on 50 mM
crotonobetaine input, the product yield of the mutant strain was about 56%, which is 30%
higher than that of the wild-type strain, 43%. The result suggests that the effect of
lipoprotein mutation is more pronounced in the later phase of the reaction. Since the
biotransformation catalyzed by L-carnitine dehydratase is a reversible reaction, we expect
that the reaction would reach its equilibrium at a certain point depending on the
intracellular concentrations of L-carnitine and crotonobetaine. Also, the L-carnitine yield
is limited by the product degradation by side reaction. Therefore, the higher product yield
by the mutant cells can be attributed to the faster product export that drives the reaction
forward and reduces the product degradation. In order to demonstrate the advantage of
mutant cells, further experiments were performed with multiple substrate replenishments.
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5.3.4.2 Biotransformation with substrate feedings
To further evaluate the potential of the lipoprotein mutant for L-carnitine
production, reactions with substrate feedings were performed as shown in Figure 5–6.
The resting-cell reactions were able to continue for 48 hours with two 100 mM
crotonobetaine replenishment at 4th and 24th hour. No further increase in the product
concentrations were observed after a third addition of crotonobetaine at 48th hour due to
the depletion of cell material and energy for the biotransformation , 64.
Figure 5–6 showed that the L-carnitine production rates were about 1.8 g l-1 h-1
and 1.6 g l-1 h-1 for the mutant and parent strains in the first two hours. The production
rates reduced to 1.0 g l-1 h-1 and 1.2 g l-1 h-1 after the first substrate addition, 37% and
33% reduction for mutant and parent strains. After the first substrate addition, the Lcarnitine concentrations reached 63 mM and 50 mM at 24th hour for mutant and parent,
respectively. Their respective product yields were 42% and 33% based on 150 mM
crotonobetain input (after one substrate replenishment). The production rates after the
second substrate addition further decreased to 0.1 g l-1 h-1, less than 10% of the level of
the first round. After 48 hours of reaction, the final L-carnitine concentrations of the
mutant and parent strain were 84 mM and 59 mM, corresponding to yields of 34% and
24% (based on a total input of 250 mM after two substrate replenishments), respectively.
From Figure 5–6, it’s evident that the difference in the product yield between two strains
increased as the reaction continued, with 42% higher yield achieved by the mutant. This
also indicates that the lipoprotein membrane mutation is capable of enhancing the L-
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carnitine yield without affecting the stability and durability of the whole cells as
biocatalysts.
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Figure 5–6. Time course of L-carnitine production catalyzed by whole-cell E. coli
O44K74Y ( ) and O44K74 (U) with 50 mM initial crotonobetaine and
two100 mM crotonobetaine replenishments at 4th and 24th hour. Arrows
represent two substrate feedings. Error bars represent standard deviations
from the mean. All data are measured in three separate experiments.
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5.4 Discussion
A Braun’s lipoprotein transposon mutation was found to be effective in
accelerating the reaction rates of whole-cell biocatalysis utilizing substrates with different
size and hydrophobicity , , . The enhancement in the reaction rates ranges from 1.5–fold to
as high as striking 14–fold. In order to find out the genetic changes corresponding to this
phenotype, the lpp region of this lipoprotein mutation E609L were sequenced and
compared with control strain. It turned out the lpp is completely inactivated by a 59-bp
insertion containing two double-stop codon at the beginning of lpp gene. Therefore, we
believe that the same phenotype could be obtained by deleting the lpp gene from the
chromosome DNA of any E. coli strain of interest. A generally applicable methodology
was established for accelerating whole-cell biocatalysis employing a high efficient gene
inactivation procedure. The characterization of lpp deletion strain showed that the mutant
grew as fast as the parent strain in both rich and minimal medium and exhibited the same
glucose consumption rate as the parent strain under both aerobic and anaerobic conditions.
The mechanisms related to these observations have yet to be discovered. Some minor
changes in the fatty acid compositions were detected (<5%), including the decrease of
short-chain (C14:0~C16:0) and cyclopropane fatty acids levels and the increase of longchain fatty acids (C17:0~C18:0) level. It suggestes that the lipoprotein mutant cells could
manage to modulate the proportions of fatty acids as a response to the lipoprotein defect.
The results also imply that compensation mechanisms are likely to exist in different
aspects of growth and metabolism to help maintenance and function for the mutant cells.

108
This study demonstrates that a useful lpp lipoprotein mutation can be applied to
solve the general permeability problems in whole-cell biocatalysis process. The lpp
knockout strains can be generated with a straightforward and high efficient gene
inactivation method. In this study, the lpp deletion was successfully introduced into E.
coli strains with different genetic background for accelerating whole-cell biocatalysis. An
example was illustrated using L-carnitine production strain E. coli O44K74 with 30~42%
increase in product yield.
We applied the useful lipoprotein mutation to L-carnitine production strain E. coli
O44K74 to achieve higher product yield. The fast initial production rates of both strains
indicated that the effect of membrane mutation on the permeability of product and
substrate (L-carnitine and crotonobetaine) was not significant at the beginning of the
reaction due to their low MW. Only 10% difference in the initial production rates was
observed in the first two hours. The effect of lipoprotein mutation was more pronounced
in the later phase of the reaction, with a product yield of 56% achieved by the mutant
strain, 30% increase over the yield of the parent strain, 43% (based on an input of 50 mM
crotonobetaine). The results suggest that the lipoprotein mutant cells are able to achieve
higher product yield by faster product export, which is crucial for forwarding the
reversible reaction and releasing the product from degradation in the L-carnitine
production. Further substrate feeding experiments confirmed the beneficial effect of
mutation on the L-carnitine production. The reactions were continued for 48 hours, and
the final L-carnitine yield after two substrate feedings were 42% higher than that of the
parent strain. This also indicates that the lipoprotein membrane mutation is capable of
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enhancing the L-carnitine yield while maintaining the stability and durability of the
whole cells as biocatalysts. These results demonstrate that a useful phenotype can now be
transferred to any E. coli strain of interest with a straightforward genetic manipulation to
effectively enhance the rate of a whole-cell biocatalysis reaction. This method might be
generally applicable to biocatalysis processes as the permeability change effected by the
mutation is of global nature.

CHAPTER 6 Summary

The past two decades has seen tremendous progress in the research of using
biocatalysts for the synthesis of high-value fine chemicals. Compared with isolated
enzymes, whole-cell biocatalysts can be much more readily and inexpensively prepared
on an industrial scale. Whole-cell biocatalysts are more stable than their isolated
counterparts and allow reaction involving multi-enzymes even multi-pathways , .
However, one major problem in whole-cell catalysis is the mass transfer limitation
imposed by the cell envelopes. As a result, the reaction catalyzed by the whole-cells is
often orders of magnitude slower than that of the isolated enzymes. Until recently, the
only effective way to address this was to permeabilize cells by chemical (such as
detergent, solvent, and chelators) or physical (such as extreme temperature fluctuations)
treatment , . These methods are far from being desirable, especially for large scale
applications, since they create additional steps in manufacturing processes, complicate
downstream processing, and incur unintended damage to cells.
In this study, we successfully reduced the membrane permeability barrier of E.
coli strains by genetically altering the membrane structure. A lipopolysaccarides E. coli
mutant (SM101) and a Braun’s lipoprotein mutant (E609L) were used in this study. As
our first test, two large model substrates (MW~600) that differ substantially in
hydrophobicity, nitrocefin, and a tetrapeptide N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide
were employed to interrogate the outer membrane of the cells. The reduction of the outer
membrane permeability by genetic methods led to significant increases (up to 380%) in
110
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reaction rates of whole-cell catalyzed reactions. The magnitude of the increase in
biocatalysis rates was also found to be dependent on the substrates and on the nature of
the

mutations

introduced

in

the

outer

membrane

structure.

Notably,

the

lipopolysaccarides mutations can render the outer membrane completely permeable to the
tetrapeptide, a barrier-less condition that maximizes the reaction rate. Subsequently, the
toluene dioxyengase (TDO)-catalyzed reaction was investigated to investigate the effect
of lipoprotein mutation on small, hydrophobic substrates. Dramatic enhancement of the
reaction rate, an increase of up to six fold, was observed over a wide range of substrate
concentrations. We also studied the effects of outer membrane mutations on a hydrophilic
large molecule, UDP-glucose (MW~600) in whole-cell systems. Owing to the severe
limitation in substrate permeability, the wild type cells only exhibited as low as 4% of
available enzyme activities. Reducing the barriers of the outer membrane permeability
led to a striking acceleration (up to 14–fold) of reaction rate in cells expressing UDPglucose dehydrogenase. Mutations in the lipopolysaccharide synthesis pathway or
Braun’s lipoprotein are both effective. An application of outer membrane mutants was
illustrated with the synthesis of a disaccharide (N-acetyllactosamine) from UDP-glucose.
Both reaction rate and product yield were enhanced significantly (more than two fold) in
the lipoprotein mutant, demonstrating the importance of the outer membrane permeability
barrier and the advantages of using outer membrane mutants in synthesis.
The impact of membrane mutations was compared with a known potent
permeabilizer PMBN (polymixin B nonapeptide). It showed that membrane
modifications to enhance the permeability of hydrophilic molecules should target the
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Lipid A region. However, molecular engineering strategies other than reduction of Lipid
A synthesis should be considered. Our study also illustrated that the mutations were much
more effective than the commonly used EDTA treatment and freeze-thaw (FT)
permeabilizing procedure. Therefore, our results demonstrated the clear advantages of
using genetic modification in cellular membrane engineering for improved whole-cell
catalysts.
Our studies , , with a Braun’s lipoprotein mutant E609L demonstrated that Braun's
lipoprotein transposon mutation in outer membrane could be an effective method to
increase permeability of a variety of substrates. The mutant exhibited a normal growth
rate and expressed the recombinant multi-component enzyme as well as the isogenic
parent strain. The results showed that reactions with all six substrates were dramatically
accelerated by this lipoprotein mutation (up to 14–fold increase in reaction rate). In order
to establish this as a generally applicable methodology for accelerating whole-cell
biocatalysis, we investigated an alternative genetic modification to obtain the same
phenotype. The lpp gene deletion was successfully introduced into E. coli strains from
different genetic background and characterized. It showed that the deletion had the same
effect on substrate permeability as the original transposon mutation. Also, the lpp
deletion was found to have no significant effect on cell growth, carbon metabolism, and
lipid compositions. As an example, the lpp deletion strain E. coli O44K74Y was
successfully applied in L-carnitine production with 42% increase in product yield. These
results demonstrate that a useful phenotype can now be transferred to any E. coli strain
with a straightforward genetic manipulation to effectively enhance the rate of a whole-
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cell biocatalysis reaction. This method might be generally applicable to biocatalysis
processes as the permeability change effected by the mutation is of global nature.
This research and the results outlined in this dissertation point to a valid strategy
in addressing permeability issues in whole-cell biocatalysis. It also highlights a need for
an assessment of substrate permeability in biocatalysis research and development. Future
study should be focused on,
1.

Application of the lipoprotein mutation in non-E. coli Gram-negative bacteria strains.

2.

Investigation of the relationship between the lipoprotein mutation to other important
substrate properties, such as spatial structure, group size and charge.

3.

Investigation of the potential effect of outer membrane mutations at other loci, such
as integral protein of outer membrane, peptidoglycan.
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APPENDIX 1.1

A short Glossary: Terminology Used in the Dissertation

Mutation: A change of the DNA sequence within a gene or chromosome of an
organism resulting in the creation of a new character or trait not found in the parent cell.
Natural mutations can occur spontaneously or in response to environmental factors such as
radiation and mutagenic chemicals. In this study, mutations were introduced into E. coli
strains using molecular engineering techniques.
Mutant: A cell or organism that has been genetically changed as a result of
mutation. The original cell is called the parent or wild-type cell.
Substrate: Substrate refers to the reactant of an enzymatic reaction.
Membrane permeability: The capability of cell membrane to allow the passage
of substrates tested. Permeability depends on both the nature of the membrane structure
and the physical properties of the substrate. In this study, the permeability is evaluated by
the reaction rate of a whole-cell catalyzed reaction.
Reaction rate: In this study, the term reaction rates refers to apparent or observed
rates of substrate utilization by host cells. Reaction rate was inferred from product
measurement.
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